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ABSTRACT
Methylphenidate (MPH) has proven efficacy with the
disruptive behaviors of children with ADHD in regular
education settings (Gully and Northup, 1997; Northup et
el., 1999; in press). Blum, Mauk, McComas, and Mace (1996)
researched the separate and combined effects of behavioral
and MPH treatments on the task engagement and disruptive
behavior of 3 children with severe to profound mental
retardation. This study used a single-subject, multielement
or alternating treatment design to assess the separate and
combined effects of MPH and behavioral treatments on the
performance of 5 children with severe to profound mental
retardation. MPH effects were evaluated within and across
dosages. Data collected in 4 to 5 analog assessments
(alone, escape, attention, tangible, control) determined
the two classroom functional analysis conditions used in
the subsequent medication evaluation. Target behavior rates
(disruptive behavior and task engagement), care provider
ratings of child behavior, and academic or task performance
measures provided comparisons across 2 or 3 levels of MPH
and placebo. Data from analog and classroom analyses were
used to develop an appropriate,

function-related behavioral

treatment for each child that included differential
reinforcement of appropriate behavior and graduated
compliance. Results indicated that 3 children demonstrated
decreased disruptive behaviors and improved task engagement
in response to MPH while 2 children demonstrated similar

vii
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improvement in response to the behavior intervention. Also,
this study (a) determined the differential effects that
stimulant medication may have on academic and behavioral
performance both within and across dosages,

(b) compared

the effectiveness of stimulant medication and a
function-related intervention in controlling problematic
behavior, and (c) determined which medication dose, if any,
was indicated for each participant. This study extends
previous behavior pharmacological research by utilizing
functional analysis of behavior disorders in relation to
medication status and developmental task variables to
assess the behavior mechanism of drug action in medication
efficacy studies. Conclusions are interpreted in relation
to the utility of functional analysis in identifying
critical assessment parameters and selecting environmental
stimuli useful in developing behavior treatments that
maximize drug action.

viii
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REVIEW OF THE LITERATURE
Definition of Mental Retardation
The definition of mental retardation has been a
controversial issue through the years

(Deitz & Repp, 1989) .

Historically, mental retardation and mental illness have
been strongly linked (Rosen, Clark, & Kivitz,

1976) . The

gradual differentiation between the two disabilities began
in the 19th century with social incompetence viewed as the
primary indicator of disability (Deitz & Repp, 1989) . With
the advent of memory and cognitive-perceptual tests, most
classification systems began to distinguish between mental
deficiency and mental illness on the basis of the
individual's potential for reasoning and complex thought
(Lewis & MacLean,

19 82).

By the turn of the century, emotional impairment was
considered the primary characteristic of mental illness,
and a cognitive deficit was considered the defining
characteristic of mental retardation (Ollendick, Oswald, &
Ollendick,

1993). In 1919, Terman introduced the

score-referenced classification levels of borderline,
moron, imbecile, and idiot and used a score of less than 80
on the Stanford-Binet Intelligence Scale as the identifying
criteria for retardation (Deitz & Repp, 1989). In the
1930s, the importance of developmental delays in behavior
existing concurrently with retardation in mental processing
was recognized (Madle & Neisworth, 1990). In 1947, the
Vineland Social Maturity Scale was introduced to assess

1
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basic social and daily living skills (Doll, 1947).
Statistical distributions of intellectual scores and
adaptive behavior estimates have been the basis of all
subsequent definitions of mental retardation (Gresham,
MacMillan, & Siperstein, 1995; Deitz & Repp, 1989).
Developmental disabilities are based on functional
skill criteria and include mental retardation, autism, and
pervasive developmental disorder not otherwise specified
(APA, 1994). Public Law 95-602

(197 8) defines developmental

disability as attributable to a mental or physical
impairment, manifested before the age of 22 years,

likely

to continue indefinitely, resulting in substantial
limitation in three or more specified areas of functioning,
and requiring specific, lifelong or extended care. Mental
retardation is distinctive among disorders in that its
diagnosis is statistically derived through a cultural
deviance rather than clinically derived through a syndrome
of specific behaviors and symptoms

(Hamilton and Matson,

1992). The three criteria defining mental retardation are
(a) significantly subaverage intelligence (i.e., greater
than two standard deviations below the mean), (b) concurrent
deficits in adaptive behavior, and (c) onset prior to age
18 (Grossman, 1983: APA, 1994). Adaptive behavior refers to
the degree of independent functioning skills, physical
development, language development, and academic competency
expected for age and cultural group (Hamilton & Matson,
1992) .

2
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Four levels of mental retardation are specified by the
individual's degree of intellectual and adaptive impairment
(Madle & Neisworth, 1990; APA, 1994). Levels include mild
(2 to 3 standard deviations below the mean), moderate

(3 to

4 standard deviations below the mean), severe (4 to 5
standard deviations below the mean), and profound (greater
than 5 standard deviations below the mean). When there are
discrepant intellectual and adaptive standard scores the
diagnosis corresponds with the higher score. Mental
retardation,

severity unspecified,

is used when there is a

strong presumption of mental retardation, but the
individual is untestable with standard testing instruments
(APA, 1994).
Prevalence and Etiology
Prevalence estimates of mental retardation range from
less than 1% to 12% with the best estimate considered to be
about 3% during the school years and approximately 1%
during the remainder of the lifespan (Scheerenberger, 1981;
Madle & Neisworth, 1990). Typically,

the diagnosis is more

common at school ages and in lower socioeconomic areas.
Approximately 10% to 15% of the population have a discrete
medical syndrome linked to their disability.
Mental retardation usually results from an interplay
of genetic and environmental factors where no organic
abnormalities are directly identifiable (Baumeister &
Sevin, 1990; Deitz & Repp, 1989). Organic or genetic
factors account for approximately 25% of all cases of

3
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mental retardation. Educational, familial, and societal
factors also contribute to mental retardation, and 40% to
90% of the individuals diagnosed with this disorder are
identifiable as cultural-familial mental retardation with
unknown etiology (Deitz & Repp, 1989).
Associated Disruptive Behaviors
Behavioral disorders were exhibited by 10% to 6 0% of
the individuals with developmental disabilities

(Sturmey,

1995), and coping with self-injury, aggression, and
resistance Lo supervision accounts for 48% of the support
worker time (Thompson, Hackenberg, Cerutti, Baker, &
Axtell,

1994). Behavior disorder severity is the single

most important variable influencing institutional placement
and is an important factor in community placement failures
(Bruininks, Rotegard, Lakin, & Hill, 1987; Aman & Singh,
1991). Behavior management is usually achieved through a
combination of psychoactive medication, applied behavior
analysis, and behavioral intervention (Baumeister & Sevin,
1990; Madle & Neisworth, 1990). Fundamental tenets of
behavior analysis are that behavioral disorders have a
significant learned component and functional assessment
methodologies have a demonstrated utility in identifying
useful treatments (Iwata, Vollmer, Zarcone, 1990). A brief
description of the associated behavior disturbances follows
emphasizing aggression and self-injury, which are the two
behaviors most likely to result in referral for medication
(Aman & Singh, 1991).

4
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Aggression
Aggression is a behavior that occurs within a social
context and is considered aversive to others. Included
within most definitions are verbal and physical assault,
fighting, destructive misuse of objects, and severe
disruptive and noncompliant behaviors

(Mulick, Hammer, &

Dura, 1991). About 20% of the individuals living at home,
16% to 20% of the individuals residing in community
residential facilities, and 30% to 45% of the individuals
in institutional settings exhibit behavior that injure
others

(Eyman, Borthwick, & Miller,

1981; Hill & Bruininks,

1984). Statistically, aggression is 1.5 to 6 times more
prevalent among institutional new admissions, community
placement failures, and reinstitutionalizations

(Schalock,

Harper, & Genung, 1981) . Physical violence toward others
and property,

tantrums, and explosive or disruptive acts

interfere with the development of adaptive behaviors

(e.g.,

social relationships and interactions) in a population
defined by adaptive social deficits

(Matson & Sevin, 199 3;

Sevin & Matson, 1994). Aggression is the primary source of
psychiatric referral among individuals with mental
retardation (Reiss, 1982; Benson, 1985).
Stereotypy and Self-injurious Behavior

(SIB)

Stereotypy and SIB are multiply determined by
neurobiological and environmental factors (Harris, 1992).
Both behaviors are prevalent in many medical syndromes

5
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(e.g., Lesch-Nyan, Cornelia de Lange, fragile X, Rett's,
and Riley-Day syndromes).
Stereotypies are rhythmical, highly consistent,
repetitive behaviors or posturing responses that are
excessive in rate, frequency, and/or intensity, clinically
conspicuous, socially undesirable, and topographically
heterogeneous

(Baumeister, 197 8; Rojahn & Sisson, 199 0; Fee

& Matson, 1992). Examples include repetitive movements,
(e.g., rocking, swaying, waving,
self -stimulatory behaviors

flapping, finger play),

(e.g., sniffing, humming,

vocalizing, mouthing, saliva or mucous play), idiosyncratic
mannerisms

(e.g., object twirling, bruxism, air swallowing)

and blindisms

(e.g., eye rubbing, poking). Stereotypy is a

characteristic of individuals with severe to profound
mental retardation but is also common among other clinical
populations

(e.g., blind, autistic, geriatric, mentally

ill). Prevalence estimates vary from one to two-thirds of
the mentally retarded population with the higher reports
being closely related with institutional placement,
severity of diagnosis, and early childhood and adolescence
(Rojahn & Sisson, 1990). Clinical problems arise in
relation to the intensity and form of the repetitive
behavior, and defining a behavior as a stereotypy or
self-injury is dependent on potential for tissue damage
(Madle & Neisworth, 1990; Fee & Matson, 1992). For example,
innocuous but repetitive, nonfunctional behaviors

(e. g.,

body rocking, hand waving) may preclude essential

6
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educational or training programs. Repetitive head rocking
may intensify into self -injurious head banging (Rojahn &
Sisson, 1990) . The most common treatments for stereotypy
have included behavior modification or therapy, physical
exercise, pharmacotherapy, and structural rearrangement of
the environment

(Rojahn & Sisson, 1990) .

SIB is defined as a highly repetitive and rhythmic act
or a class of behaviors resulting in direct physical harm
to the person exhibiting the behavior, restricting spatial
and temporal topographies, and occurring at a reliable,
observable rate (Schroeder, 1991; Schroeder, Rojahn,
Mulick, & Schroeder, 1990; Fee & Matson, 1992).
Self-hitting, hair-pulling, self-scratching, and
self-gouging of eyes, ears, mouth,

throat, nose, and rectum

are frequently reported types; however, head-banging and
self-biting are the most common forms of SIB among persons
with mental retardation (Thompson, Axtell, & Schaal, 1993) .
SIB occurs along a severity continuum from repetitive face
rubbing to life-threatening head banging (Fee & Matson,
1992) . Unlike suicidal gestures, self-neglect, and
self-mutilation, SIB occurs without the apparent intent of
self-harm.
SIB occurs in 6.5% of people with mental retardation
living in community settings and in 15.4% of those living
in public residential settings, with 20,000 to 25,000
displaying severe SIB (Thompson et al., 1994). SIB occurs
in 40% of hospitalized children with psychotic diagnoses

7
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and in 7% to 30% of individuals with neur©developmental
delays

(Sandman, Hetrick, Taylor, & Chicz-DeMet, 1997).

People with SIB are costly to serve. Time spent managing
SIB accounts for 62% more staff time than does aggressive
outbursts

(Silverstein, Olvera, & Schalock,

1987) .

SIB is viewed as an exacerbated form of stereotyped
behavior, with a common etiologic base but marked
idiosyncratic differences with regard to topography,
severity,

frequency, and duration (Baumeister & Forehand,

197 3). In its most severe form, SIB may result in extensive
tissue damage, fractures, amputation, and death, and is
considered the most severe behavior problem encountered by
service providers

(Mace, Lalli, & Shea, 1992).

Hyperactivity

Hyperactivity refers to behavior that is excessive,
situationally inappropriate, or specific to a psychological
syndrome such as Attention Deficit Hyperactivity Disorder
(ADHD) and may be associated with conditions including
anxiety, mania, schizophrenia, hysteria, hypoglycemia,
hyperthyroid, and akathisia (Coe & Matson, 1993; Chandler,
Gualtieri, and Fahs, 19 88). Differential diagnosis is
difficult for individuals with profound or severe mental
retardation, who characteristically exhibit attention
deficits and activity excesses. A multimodal assessment,
combining psychiatric, pharmacological, and direct
observation techniques, is required with this population
(Coe & Matson, 1993). Biochemical substrates assumed to

8
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underlie hyperactivity include the catecholamines,
dopamine, and norepinephrine; however, the primary evidence
for these theories rest in the action of drugs used to
treat hyperactivity on these transmitter systems
(Baumeister & Sevin, 1990).
Hyperactivity has generally been considered an
essential component of ADHD; however, ADHD has undergone a
number of changes in the Diagnostic and Statistical Manual
of Mental Disorders (DSM). Identified as hyperkinetic
reaction of childhood in DSM-II and attention deficit
disorder in DSM-III, the disorder continues as attention
deficit/hyperactivity disorder in DSM-IV, and the criteria
for the disorder also includes either symptoms of
inattention or hyperactivity.
Behavioral Treatment Approaches
Interventions for persons with mental retardation have
centered on behavioral approaches with less emphasis on
psychiatric diagnosis (Fisher, Piazza, & Page, 1989).
Behavioral theories of disruptive behaviors maintain that
the aberrant behaviors frequently associated with
individuals with mental retardation are learned behaviors
maintained by their consequences

(Beier, 1964; Gardner &

Sovner, 1994). Carr's (1977) review of the SIB literature
suggested three operant hypotheses related to the
development and maintenance of self-injury:
mediated positive reinforcement,

(a) socially

(b) socially mediated

9
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negative reinforcement, and,

(c) sensory or automatic

reinforcement.
Socially mediated reinforcement is when consequences
delivered by another person strengthen a behavior. An
example of socially mediated positive reinforcement is a
statement of concern or reprimand resulting in a behavioral
increase when presented following incidents of SIB.
An example of socially mediated negative reinforcement
is the removal of an instructional activity as a
consequence for disruptive behavior, which results in
increased rates of behavior on subsequent instructional
presentations. Thus, a care provider responding to SIB by
removing a task or instruction may inadvertently reinforce
the behavior, and SIB becomes functional in escaping
ongoing aversive or unattractive activities or avoiding
anticipated unpleasant situations (Gardner & Sovner, 1994).
Automatic reinforcement refers to situations where
behavior generates its own reinforcement. Common labels for
automatically reinforced disruptive behaviors include
stereotypy, self-stimulation, and repetitive mannerism
(Vollmer, 1994). An example of automatic positive
reinforcement is when eye poking automatically stimulates
the area around the eye. Automatic negatively reinforced
behaviors result in response-contingent termination of
aversive physiological conditions (e.g., ear or tooth ache,
chronic dermatitis). Examples include scratching the skin

10
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after an insect bite or ear-hitting when experiencing ear
infections

(Cataldo & Harris, 1982) .
Behavioral Assessments and Treatments

Initially, within the field of developmental
disabilities, interventions were developed and applied
based on behavior topography rather than function. Clinical
assumptions about the underlying psychopathology of an
exhibited behavior

(SIB) were made and behavioral or

psychopharmacological treatments were prescribed
accordingly. Treatments were applied sequentially in
accordance with a least-to-most restrictive method and/or
by reviewing the literature for previous treatment
applications with that target behavior form or topography
(Thompson, et al., 1993).
The current dual behavior assessment process includes
(a)

a topographical inventory of individual behavioral

strengths and deficits and (b) functional analysis of
behavior excesses (Sturmey, 1996). Standardized checklists
and scales, observations, and interviews are used to
identify behavioral strengths and weaknesses

(Hamilton &

Matson, 1992). Topographical assessments are used in
group-based research and clinical outcome studies

(Sturmey,

1996). The second level of behavior assessment is
prescriptive, functional assessment to identify the
controlling contingencies that will lead to appropriate and
effective intervention selection (Madle & Neisworth, 199 0;
Rojahn & Sisson, 1990). Current trends are to use

11
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functional analysis to incorporate more sophisticated
rearrangements of existing consequences into natural
counteracting interventions

(Mace et al., 1992).

Functional Analysis
Current functional analysis procedures are designed to
either identify or rule out social contingencies. Within
the protocol, conditions are deliberately manipulated to
expose participants to particular antecedents and
consequences. Consistently high aberrant-behavior rates in
a test condition suggest that a functional relationship
exists (Iwata, Dorsey, Slifer, Bauman, & Richman,
19 82/1994) . Specifically, antecedent and consequent events
particular to that condition are considered to be
functionally related to the problem behavior.
Iwata et al.

(1982/1994) empirically tested Carr's

(1977) operant hypotheses in the assessment of SIB for nine
individuals. Two types of contingencies

(e.g., positive and

negative reinforcement) and two sources of stimulus
delivery or removal

(e.g., socially mediated versus

automatic) made up the four standardized components used to
suggest different types of behavioral interventions for
SIB. The experimental conditions were
(b)

(a) academic demand,

reprimand, and (c) alone in an austere environment to

determine if SIB persisted in the absence of social
reinforcement. The control or play condition involved no
instructional demands, noncontingent attention, and free
access to leisure materials. Results demonstrated that the

12
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functions of SIB were idiosyncratic across individuals. For
example, SIB appeared to serve a positive reinforcement
function for participants who engaged in increased rates of
SIB during the reprimand condition. Higher rates of SIB
during the demand condition suggest a negative
reinforcement function. Finally, some participants
exhibited high levels of SIB in the alone condition,
suggesting that SIB was not maintained by social
consequences.
In summary, the functional analysis protocol
deliberately manipulates test conditions to expose
participants to particular antecedents and consequences.
Consistently high aberrant-behavior rates in one or more
test conditions suggest that a functional relationship
exists

(Iwata et a l ., 1982/1994). Specifically, antecedent

and consequent events particular to the condition are
considered functionally related to the target behavior and
incorporated into behavior reduction interventions.
Numerous other researchers have demonstrated the
utility of functional analysis. For example, Sasso et al.
(1992) used the same basic protocol to demonstrate the
applicability and utility of functional analyses of
disruptive behaviors

(aggression and inappropriate

language) in school settings with two children with autism.
Fisher et al.

(1989) and Northup et al.

(1999; in press)

have used functional analysis to evaluate the interaction

13
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effects of concurrent behavioral and pharmacologic
interventions.
Function-related Interventions
The goal of functional analysis is to match the
intervention to the results of the functional assessment by
utilizing existing environmental conditions. Functional
analysis may also suggest eliminating some common
treatments. The three guidelines for incorporating
functional analysis results into treatment design are
(a) eliminate or weaken reinforcers identified as following
inappropriate behaviors,

(b) provide the same reinforcer

for alternative, appropriate behaviors, and (c) use
antecedent manipulations identified in functional analysis
(e.g., appropriate task or curriculum, instructional
modifications). Thus, once a behavioral function is
identified it may become possible to eliminate reinforcing
contingencies (extinction), present reinforcement for more
appropriate alternative behaviors (differential
reinforcement), or alter the efficacy of the reinforcer
maintaining the problem behavior

(establishing operations).

Pharmacotherapy
Pharmacotherapy or psychopharmacology for individuals
with mental retardation primarily involves psychotropic and
psychoactive medications used to manage behavior considered
to be harmful to the individual (SIB), to others
(aggression), or to control behavior that may interfere
with training or education (e.g., hyperactivity,

14
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stereotypy). Less frequently, medications are also used to
treat intellectual impairments or emotional disorders
(Baumeister & Sevin, 1990). Psychotropic medication is any
substance administered for the purpose of producing
behavioral, emotional, or cognitive changes; a psychoactive
drug is any agent that has such effects regardless of the
purpose of prescribing the medication (Aman & Singh, 1988) .
Research and clinical prescription of psychotropic
medications for persons with mental retardation differ from
other areas of neuropsychiatry. Typically, little
consideration is given to the actions of the neural
substrates that underlie the created conditions.
Psychopharmacological treatment in the field of mental
retardation is directed more toward suppression of
behavioral symptoms than matching known agents to
well-defined disorders as in adult psychiatry (Baumeister &
Sevin,

1990; Aman & Singh, 1991). Pharmacologic treatments

focus on the target behavior and generally serve
suppressive functions

(Thompson, et al., 1993). Thus, drugs

used to control the behavior of persons with mental
retardation without any clear theoretical rationale, may be
countertherapeutic (Baumeister & Sevin, 199 0).
Commonly Used Medications
Most drugs prescribed for behavior disturbance and
psychopathology in individuals with mental retardation have
been borrowed from other clinical populations. Before 1950,
hypnotic drugs (e.g., chloral hydrate and paraldehyde) were

15

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

the primary pharmacological behavior management agents used
with individuals exhibiting mental retardation. These
medications were used as sleep-provoking medications at
night and to sedate persons displaying aberrant behavior
during the day (Thompson, Hackenberg, & Schaal, 1990;
Schaal & Hackenberg, 1994). In 1955, Blair and Herold used
chlorpromazine for behavior problems exhibited in people
with mental retardation. Phenothiazines very quickly,
became the treatment of choice for institutionalized people
displaying agitation, aggression, or SIB. The use of modern
psychiatric medications to treat behavior disturbance among
individuals with mental retardation subsequently grew
rapidly for two decades

(Thompson et a l ., 1990).

The neuroleptics established a pattern of the
treatment for severe behavior disturbances in individuals
with mental retardation that has been replicated by
virtually every available psychotropic medication.
Generally,

the goal is to reduce aggressive behavior, SIB,

agitation, property destruction, and stereotypies

(Schaal &

Hackenberg, 1994).
Patterns of Drug Use
Persons with mental retardation are among the most
medicated population in our society (Aman & Singh, 1991).
From 30% to 50% of institutionalized individuals with
mental retardation are medicated. Between 25% and 35%
typically receive anticonvulsant medication. Thus, 50% to
67% of the residential population with mental retardation
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are receiving either a psychotropic or anticonvulsant
medication (Aman & Singh, 1991). The most often prescribed
medications within institutions include psychotropic drugs
(thioridazine, chlorpromazine, diazepam, haloperidol,
mesoridazine, and hydroxyzine) and antiepileptic drugs
(phenobarbital, phenytoin, primidone, carbamazepine, and
sodium valproate). Stereotypies, aggression, and SIB are
frequently treated with neuroleptics, anticonvulsants,
antidepressant and antimanic drugs, anxiolytic drugs
(benzodiazepines), and stimulant drugs.
Baumeister, Todd, and Sevin (1993) reviewed more than
three dozen studies and reported prevalence differences for
persons with mental retardation residing in institutions
and community or school based settings reflect varying
degrees of handicap and different rates of aberrant
behavior. As noted in Table 1 below, the mean prevalence of
psychotropic medication use in persons with mental
retardation varied greatly in relation to the type of
residential placement.
Table l. Psychotropic Prevalence: Mean Percentage for
Persons with Mental Retardation
Drug
Institutions
Supported Living
Schools
All psychotropics
Anticonvulsants
Neuroleptics
Antidepressants
Anxiolytics
Sedative/hypnotics
Stimulants

57 .4
31.6
31.8
2.9
8.5
6.0
0.5

41.4
21.6
19 .0
5.0
3.8
2.6
0.5

22 .8
15 .4
4.4
0.9
0.1

The high prevalence of anticonvulsant use is related to the
high incidence of convulsive disorder and the use of this
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drug class to manage aberrant behavior in persons with
mental retardation independently of their anticonvulsant
effect (Beaumeister et al., 1993).
Tu and Smith (1983) noted the six most common problems
and prevalences among medicated individuals with mental
retardation are as follows: aggression (29%), hyperactivity
(24%), SIB (19%), excitability (12%), screaming (10%), and
anxiety (8%). Hyperactivity was the strongest predictor for
neuroleptic use in community residential facilities;
violent or destructive behavior was the strongest predictor
for neuroleptic use in institutions

(Intagliata & Rinck,

1985).
Methodological Considerations
Minimal requirements for a scientifically controlled drug
study are as follows: placebo control, random assignment of
subjects

(group comparison designs), adequate baseline and

reversal phases

(single-subject or within-subjects

designs), double-blind observations or evaluations of drug
effects to minimize bias, standardized doses, direct or
standardized (valid, reliable) measures of drug effect
(behavior change), and appropriate use of inferential
statistics

(group designs) or visual analysis

(single-subject designs)

to measure drug-related changes

(Sprague & Werry, 1971; Aman & Singh, 1988, 1991;
Baumeister & Sevin, 1990; Thompson et a l ., 1990; Singh,
Singh, & Ellis, 1992; Schaal & Hackenberg, 1994) .
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Pre-197 5 studies in the field of mental retardation
violated one or more of the above mentioned criteria and
were clearly inferior to work occurring with other clinical
populations

(Aman & Singh, 1988). The difficulties in

working with persons with developmental disabilities make
it challenging to conduct elaborate research. The number of
adequately controlled studies have consistently increased
during the past twenty years (Aman & Singh, 1988;
Baumeister et al. 1993). Additionally, studies are
appearing with specific indications for the various
psychotropic drugs prescribed for persons with mental
retardation (Fisher et al., 1989; Johnson, Handen,
Lubetsky, & Sacco, 1994; Aman, et al., 1997; Christian,
Kerr, Sutphin, & Poling, 1997).
Well designed studies in the field of mental
retardation (a) describe medication effects on specific
behaviors,
(c)

(b) separate the effects of different drugs,

separate the drug effects for participants with mental

retardation from other individuals (Baumeister et a l .,
1993), and (d) control for environmental variables. Aman
and Singh (1988; 1991) urge medication trials be free of
other drug confounds and be compared to alternative
interventions.
Measuring Dose-Response Relationships
The dose-response relationship is the orderly
relationship between the quantity of a drug and the
magnitude of effect. Psychopharmacological research
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measurement techniques commonly used to measure drug
effects require adjustments for the cognitive and
behavioral deficits of persons with mental retardation.
Baumeister and Sevin (199 0) are critical of studies that
lump disruptive behaviors and provide only a global measure
of change

(e.g., percent improved). Drugs may have

differential effects on a given behavior or classes of
behavior at different doses. Singh et a l . (1992) recommend
studies include measures of collateral behaviors

(e.g.,

learning, adaptive and maladaptive behaviors) as well as
dosage effects to determine dose-dependent relationships.
Global impressions. Global impressions are ratings of
overall behavior change or clinical improvement based on
the rater's subjective impressions of the participant

(Aman

& Singh, 1988; Baumeister & Sevin, 1990). Although useful
as general indicators of change from the subjective opinion
of service providers, global impression measures lack
objective criteria against which changes can be judged and
should not be used in isolation. For example, teachers will
rate changes in learning and cognition more positively than
support workers in custodial settings

(Baumeister & Sevin,

1990) .
Direct behavioral observations. Direct behavioral
observations are less prone to bias but have only recently
become common in psychopharmacological research with
persons with mental retardation (Aman & Singh, 1988).
Within the direct observation method, principles of applied
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behavior analysis are used to select and define target
behaviors, complete initial descriptive analyses, and
sample a broad range of maladaptive and adaptive behaviors
using standardized procedures of data collection (Singh &
Beale, 19 86).
Rating scales. Rating scales have been the major
assessment procedure of behavior change in pediatric
psychopharmacology but have less prevalence in studies with
individuals with mental retardation (Aman & Singh, 1988).
There are numerous scales designed for measuring behavior
change in developmentally delayed populations, but most
have not been used in psychopharmacological investigations
(Aman & Singh, 19 88). Only a small number of scales normed
with this population have demonstrated adequate
psychometric properties in psychopathological assessment
(Aman & Singh, 19 88).
Learning measures. Learning measures are indices of
cognition and learning that are recommended for inclusion
in the assessment of drug effects

(Sprague & Werry, 1971;

Aman & Singh, 1988) . IQ tests, achievement tests,
curriculum measures, vocational training tasks, and
performance tests for attention or dexterity have been used
as learning measures. Assessing drug-related change in
learning performance is difficult with a population having
major learning and cognition deficits. Aman and White
(19 86) reviewed a number of tasks (e.g., operant
conditioning and discrimination learning tasks)

that appear
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to have some utility as learning measures in
psychopharmacological research. In general, IQ and
achievement tests appear to be the least sensitive to
medication effects, and the literature suggests performance
tests are most likely to be effected by medication (Werry &
Sprague, 1972; Aman & Singh, 1988).
Physiological measures. Dependent measures in
psychopharmacology research generally require the
participant's active involvement. Functional level,
associated physical impairments, and behavior problems may
preclude compliance for persons with mental retardation.
Physiological measures are an alternative method of
assessing medication effects. Aman and White (19 86)
recommend physical measures of motor coordination,
physiological measures

(e.g., galvanic skin response, heart

rate), and play or activity measures

(e.g., mechanical

transducers) as useful tools.
Behavior Pharmacology
Behavior pharmacology recognizes the significance of
pharmacological variables

(e.g., dose) as determinants of

drug action, but places primary emphasis on behavioral and
environmental variables that have been demonstrated to
modulate drug effects.
To understand the mechanisms of a drug's action in
changing behavior, it may be advantageous to search for
behavior mechanisms of drug action. A behavioral mechanism
of action describe a drug's behavioral effects in terms of
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alterations made on environmental variables normally
regulating that behavior

(Thompson & Schuster, 196 8;

Thompson, 1984). Specifying the behavioral mechanisms
responsible for an observed effect involves

(a) identifying

the environmental variables that typically regulate the
behavior in question, and (b) characterizing the manner in
which the influence of those variables is altered by the
drug (Thompson, 1981). For example, a drug could weaken the
effectiveness of known rewards or reinforcers, or diminish
the efficacy of punishing events in suppressing destructive
or aggressive behavior

(Northup, et al., 1997).

A Functional Approach in Medication Studies
Schaal and Hackenberg (1994) criticize studies that
select participants based on topographical features of the
problem behavior

(e.g., self-hitting) without considering

the function of the behavior. These authors recommend a
pharmacotherapeutic approach that includes functional
analyses of behavior disorders with appropriate
consideration of the pharmacological agent and
developmental variables involved.
Thompson et al.

(1993) recommend an analysis of the

behavior mechanism of drug action in drug efficacy studies.
For example, four classes of behavioral mechanisms of drug
action relevant to SIB include (a) neuroleptic reduction of
SIB when the behavior problem is maintained by terminating
conditioned negative reinforcers,

(b) neuroleptic reduced

control of reinforcing stereotypic stimulation,

(c) opiate
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antagonist blocking of the reinforcing effects of
endorphins binding to the opiate receptor, and (d) the
benzodiazepine exacerbation of SIB with the antisuppressive
effects diminished in strength by the natural painful
results

(Thompson et al., 1994). Thompson et al.

(1993)

advocates a tri-dimensional analysis of SIB that includes
establishing the temporal pattern and repetitiveness of the
SIB, the degree it is under external environmental control,
and the degree pain serves as a maintaining event.
Stimulant Medications and Mental Retardation
CNS stimulant medications, such as methylphenidate
(MPH) or Ritalin, dextroamphetamine (dexedrine), and
pemoline (cylert), are the medications of choice for ADHD.
MPH is the most prescribed stimulant medication and
imipramine (Tofranil) and fenfluramine are the most
prescribed for stimulant nonresponders (APA, 1994).
Although it shares a similar pharmacologic profile with
amphetamine,

therapeutic doses of MPH have a more marked

effect on cognitive functions than physical or motor
activities.
Reported side effects of stimulant medications include
stomach ache, headache, depressed appetite, insomnia,
dizziness, and tics. Ahmann et al.

(1993) systematically

addressed the frequency and severity of associated
stimulant-related side effects and found only four symptoms
(stomach ache, headache, decreased appetite, and dizziness)
were reported to increase over baseline with stimulant use.
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Nolan and Gadow (1997) studied the differential effects of
doses of MPH (0.1 to 0.5 mg/kg) and placebo in normal-IQ
children with ADHD and chronic motor tics. Dramatic
improvement was noted in 32% of the 34 children receiving
the 0.5 mg/kg dose and no increases in tics were noted.
Handen, Feldman, Gosling, Breaux, and McAuliffe

(1991)

found stimulant use induced motor tics (11.1%) and social
withdrawal

(7.4%) in 27 children dually diagnosed with

mental retardation (IQs 48 to 74)and ADHD.
Dosage
MPH is a mild CNS stimulant and is manufactured in
doses of 5, 10, 20 mg, and sustained release, 20 mg
tablets. The drug has a relatively brief half-life with the
behavioral effects of MPH peaking approximately 1 ^ hours
after ingestion, and decreasing gradually until they
disappear approximately 2 hours later. The time-response
curve of MPH indicates that the behavioral effects increase
for the first two hours after administration, and decrease
in what is similar to a bell-shaped curve (Pelham, Jr.,
1993). MPH is expected to be eliminated entirely from the
body within 24 hours after ingestion. Some studies suggest
that sustained-release MPH may be less effective in the
first hours after administration. Thus, short-acting MPH is
prescribed more often than the sustained-release dose
(DuPaul, Barkley, & McMurray, 1991; Barkley, 1989).
Body weight

(mg/kg) and blood levels are not always

accurate predictors of dose-response to stimulant

25

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

medication. Additionally, idiosyncratic responses occur
(a)

across behaviors for the same child and (b) between

children of the same weight, height, and gender for similar
behavior

(DuPaul & Barkley, 1993). A particular dose may

increase a child's academic performance, but fail to make
substantial decreases in disruptive classroom behaviors
(Sprague & Sleator, 1977). Therefore,

individualized

evaluations of MPH effects are recommended.
MPH Effects across Behavioral Classes
The idiosyncratic effect of MPH across behavior
classes

(e.g., academic performance, attention, social

interaction) has immediate and long-term implications when
choosing behaviors to be targeted in assessment and
intervention (Rapport & Kelly, 1991). Sprague and Sleator
(1977) conducted the seminal study assessing multiple
behaviors

(social behavior, learning performance) across

different doses of stimulant medication (placebo, 0.3
mg/kg, and 1.0 mg/kg) by using the Abbreviated Conners
Teacher Rating Scale (ACTRS) and a picture recognition task
at three levels of increasing difficulty (3, 9, and 15
pictures). Results indicated that learning performance was
optimal at the lower MPH dose level but teacher ratings
were optimal at the higher MPH dose level.
A series of clinic-based studies evaluated the effects
of four doses of MPH (5, 10, 15, and 20 mg) and a placebo
on the school and clinic behaviors of children diagnosed
with ADHD

(Rapport & Kelly, 1993). Weekly, clinic measures
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were compared to three classroom observations. Clinic
measures included the Continuous Performance Task (CPT),
the Matching Familiar Figures Test (MFFT), and the Paired
Associate Learning (PAL) task. Classroom measures included
academic performance, on-task behavior, and teacher ratings
of overall classroom behavior. The classroom measures were
highly sensitive to both overall and between dose effects
while most of the clinic measures were found to be
insensitive in detecting overall and between dose MPH
differences. The MFFT did indicate overall and between dose
differences with the 15 mg dose when compared to the lower
doses (5 and 10 mg) and placebo (Rapport & Kelly, 1993) .
Rapport, Stoner, DuPaul, Birmingham, and Tucker

(19 85)

used a triple-blind, placebo-controlled, crossover
experimental design to evaluate the performance of children
receiving three dosages of MPH (5, 10, and 15 mg) on the
clinic-administrated PAL measures and multiple,
school-related behaviors (teacher ratings, on-task, work
completion, and accuracy). An ANCOVA with repeated measures
computed on all dependent variables indicated
(a)

significant dose effects on teacher ratings, percent

on-task, and academic accuracy,

(b) significantly higher

teacher ratings for the placebo condition compared to all
medication conditions, and (c) significant differences in
all dependent measures, except the PAL task, with higher
doses typically effecting the most change. When the PAL
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task results were analyzed separately, the children showed
response to medication dosage.
Rapport, DuPaul, Stoner, and Jones (19 86) evaluated
the utility of classroom observations and the CPT in
detecting dose-response effects of three levels of MPH (5,
10, 15 mg) in a double-blind, placebo-controlled crossover
design. CPT variables included CPT omission and commission
errors and percent of on-task behavior, completed
assignments, correctly completed assignments, and teacher
ratings. Statistical analysis indicated significant overall
effects for all dependent measures; however, analyses at
the individual level showed an idiosyncratic response
across children. The individual responses to MPH were task
specific for some children.
Methodology in Stimulant Medication Evaluations
General Assessment Procedures
The ADHD-stimulant medication efficacy studies have
been prominent in developing a systematic behavioral
investigation to determine drug-behavior interaction. In
clinical practice, the rationale for dosage selection is
usually not determined in an objective manner

(Gadow,

Nolan, Paolicelli, & Sprafkin, 1991).
Physicians typically use a physical exam and a
parental interview that stresses history and nature of the
presenting symptoms (Barkley, 1987; DuPaul & Barkley,

1993;

Gulley & Northup, 1997) . A single office visit will often
generate a diagnosis and a prescription for stimulant
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medication at the lowest dose, to be titrated upward as
indicated by parent reports at subsequent visits. The
traditional prescriptive approach to stimulant medication
fails to recognize the complexity of stimulant medication
effects and the individual needs of the children for whom
the medication is prescribed. Pelham, Jr.,

(1993) cautions

that the traditional prescriptive practice may result in
many children either receiving an inappropriate dose or
being prescribed stimulant medication when it is
contraindicated.
Recent research indicates most of the common
assessment procedures do not adequately evaluate all the
behavioral areas that stimulant medication affect

(DuPaul &

Barkley, 1993; Gulley & Northup, 1997). Behavioral
assessment procedures (e.g., direct observations, academic
performance measures, behavior ratings across raters) are
adapted to stimulant medication assessments that require
measures of behavior change, dosage effects, social
validity, and convergent validity of observational measures
with data from other sources (Pelham, Vodde-Hamilton,
Murphy, Greenstein, & Vallano, 1991). The more common
behavioral assessment procedures and traditional laboratory
tests of attention and impulsivity are reviewed below.
Laboratory Assessments
Clinical evaluations of dose response use general
performance tests that assess impulsivity and attention.
The measures are considered sensitive to medication
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effects; however, predictive validity related to the
child's actual classroom behavior is low. The measures do
not detect changes in the multiple areas of functioning
that may be affected by stimulant medication (Rapport &
Kelly, 1993).
Continuous Performance Task (CPT; Rosvold. Mirskv.
Sarason. Bransome. & Beck. 19 56). The CPT is a widely used
laboratory measure of the vigilance or attention span of
children with ADHD. The child presses a button when a
previously specified number or letter appears in a rapidly
presented numerical or letter sequence. The test yields
scores of sustained attention (the number of correct
responses,

the number of missed stimuli or omission

errors), and a score of impulsivity (the number of
responses to inappropriate stimuli or commission errors).
Gordon Diagnostic System (GPS: Gordon. 1983). The GDS
is a CPT variation that uses a computerized,

9 -minute

vigilance task. The child presses a large button after
specified numerical sequences. The GDS has satisfactory
normative data and test-retest reliability. It is
considered sensitive to moderate to high doses of stimulant
medication and discriminates ADHD from non-ADHD children
(Barkley, 1990).
Matching Familiar Figures Test (MFFT: Kagan. 1966).
The MFFT is the most widely used clinical measure of
impulsivity. The child identifies one correct stimulus
picture from six similar variations during 12 trials. The
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test generates a total error score (number of incorrect
identifications) and a latency score (mean time between the
presentation of a stimulus card and the subject's initial
response). Some studies have reported conflicting or
negative results in regard to stimulant drug effects or
failed to discriminate between children with and without
ADHD (Barkley, 1990) .
Delay Task (Gordon. 1983). The Delay Task is an
8 -minute measure of impulsivity that incorporates the GDS
program with a differential reinforcement of low rates
paradigm. More points are earned if the child successfully
delays button pressing following presentation of the
specified sequence. The Delay Task has normative data and
discriminates between ADHD and non-ADHD children; however,
it may not be sensitive to stimulant drug effects and
correlates poorly with parent and teacher ratings
Fischer, Newby & Breen, 1988; Barkley,

(Barkley,

1990).

Teacher's Self-Control Rating Scale (TSCRS: Humphrey.
1982). The TSCRS is a 15-item teacher rating scale that
assesses self-control. Teachers rate behaviors on a 5 -point
Likert scale from 1 (never happens) to 5 (often happens) .
The scale yields scores for a behavioral/interpersonal
factor score, a cognitive/personal self-control factor, and
total self control. The TSCRS has demonstrated adequate
psychometric properties and positive correlations with
naturalistic behavioral observations

(Rapport et a l ., 1985;

Humphrey, 1982).
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Paired Associate Learning (PAL). The PAL task was
developed to determine optimal stimulant dose and stimulant
responsiveness

(Rapport et a l ., 1985). A series of familiar

animal picture cards are presented, assigned specific zoo
numbers, and shuffled. The child verbally matches the
animal card with the appropriate zoo number from 10 trials.
Academi c
Academic measures of stimulant medication effects must
be administered repeatedly across doses. Standardized
academic achievement tests are not sensitive to the
productivity and accuracy changes that occur in repeated
medication trials (DuPaul & Barkley, 1993).
Permanent work products. Academic performance response
to medication effects is measured with permanent work
products

(e.g., academic productivity and accuracy ratings

of routine, daily, teacher-assigned tasks). Academic
productivity measures include the number of academic tasks
completed (e.g., number of problems worked, number of words
read) or the number of units produced. Accuracy is the
number of items worked or completed correctly

(percent

correct).
Curriculum based measurement

(CBM). CBM appears to be

an effective measure of academic performance in stimulant
medication trials (Gulley and Northup, 1997; Stoner, Carey,
Ikeda, & Shinn, 1994). CBM uses a behavioral-assessment
perspective to evaluate academic performance in reading,
math, spelling, and written expression (Shinn, 1989). CBM
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measures make direct and repeated assessments of a child's
academic performance and use graphed results as time series
data in ongoing decision making. CBM measures have compared
favorably with teacher ratings on the Academic Performance
Rating Scale (APRS; DuPaul, Rapport, & Perriello, 1991; the
Child Attention Problems scale (CAP; Barkley, 1990), and
the Side Effects Rating Scale (SDERS; Barkley, 1990).
Social Skills
Social difficulties and poor peer relationships are
among the most pervasive problems children with ADHD
experience and are considered significant predictors of
long term maladjustment

(Hoza, Pelham, Jr., Sams, &

Carlson, 1992). The majority of medication studies have
concentrated on authority rather than peer social
relationships

(Hinshaw, 1991; Klorman et a l ., 1988). Thus,

most studies assess changes in the child's social skills
with the parent or teacher

(Hinshaw, 1991; Klorman et a l .,

19 88), and a few studies have targeted social skills with
peers

(Pelham et al., 1987; Hinshaw, Henker, Whalen,

Erhardt, & Dunnington, 1989; Gulley & Northup, 1997;
Northup, Jones et al., 1997).
Hinshaw et al.

(1989) evaluated the effects of

stimulant medication on the noncompliance, aggressive, and
social behaviors of 25 boys with ADHD with two doses of
MPH. The nonsocial category was added to measure decrease
in sociability or the zombie effect teachers or parents
attribute to an overmedicated child. Main effects were
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found for noncompliance and aggression during the
medication trials, but no effects were found for prosocial
or nonsocial behavior.
MPH may be effective in decreasing negative
verbalizations, conduct problems, and negative peer
interactions for some children with ADHD (Pelham & Bender,
1982; Pelham & Hoza, 1987). Most studies have combined
medication with various behavioral treatments. Group
studies of children with ADHD and average intelligence have
found that behavioral treatments in combination with low
doses of MPH are more effective than either intervention
alone (Carlson, Pelham, Milich, & Dixon, 1992; Pelham
Milich, & Walker,

19 86). The degree to which these group

studies characterize the response of individual children to
these interventions is not known. More research is needed
to determine the separate and combined effects that
medication and behavioral interventions may have on the
children's social and classroom behaviors

(Blum, Mauk,

McComas, & Mace, 1996; Gulley & Northup, 1997; Northup et
a l ., 1999; in press). Current literature is limited by the
narrow range of studies, the use of different doses of
medication, and the lack of systematic dose manipulation
(Cunningham, Siegel, & Offord, 19 85).
Multimethod Stimulant Medication Assessments
School Based Medication Evaluation (SBME)
SBME (Gadow, 1991) is a standardized observation
method that uses behavior rating scales and direct
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observations of child behavior to evaluate medication
effects. SBME uses a target behavior response rate at
placebo and each level of medication to establish a minimal
effective dose for each child. The protocol includes
parent and teacher rating scale,
effects checklist,

(a) a

(b) a stimulant side

(c) direct observations of disruptive

behaviors with the Classroom Observation Code (Abikoff &
Gittelman, 19 85), and (d) direct observations of social
behavior with the Code for Observing Social Activity

(COSA;

Sprafkin & Gadow, 19 87) .
Other Multimethod Approaches
Fischer and Newby (1991) developed a clinical protocol
to assess medication effects for children with ADHD using
(a)

a double blind procedure and a weekly randomized

rotation of medication status at placebo and low (0.2 mg/kg
BID) and high (0.4 mg/kg BID) doses of MPH,

(b) an initial

clinical evaluation that included the Child Behavior
Checklist

(CBCL; Achenbach & Edelbrock; 1993),

(c) weekly

parent and teacher rating scales, and (e) weekly laboratory
measures

(the Multi-Choice Reaction Timer,

the GDS

vigilance task, and a restricted academic task). Weekly
parent rating scales included the Home Situations
Questionnaire

(HSQ; Barkley, 1991), the Conners' Parent

Rating Scale-Revised (Goyette, Conners, & Ulrich, 1978),
and the Side Effects Rating Scale. Weekly teacher rating
scales were the School Situations Questionnaire

(SSQ;

Barkley, 1991), the Conners' Teacher Rating Scale-Revised
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(CTRS-R; Goyette et a l ., 1978), and the Side Effects Rating
Scale. The protocol yields measures of reaction time,
sustained attention, impulsivity, and a variety of child
behaviors during the restricted academic situation.
Recent single-subject studies with children with ADHD
have extended the Fischer and Newby (1991) protocol by
developing a comprehensive assessment procedure across
multiple behavior measures to determine (a) an optimal dose
of stimulant medication,

if any,

(b) medication effect

variations across doses, and (c) medication effects across
child behaviors.
Gulley and Northup (1997) used a double-blind,
placebo-controlled, single-subject experimental design to
evaluate the effects of three doses of MPH (low, moderate,
and high) across the behavioral domains of academic
performance, classroom behavior, attention, social
interactions, and teacher ratings of child behavior.
Results suggested CBM and direct behavior observations were
sensitive to medication response for all students. Northup
et al.

(1999; in press) used a double-blind,

placebo-controlled, multielement design and functional
analysis assessments within the classroom setting to
demonstrate the differential effects that stimulant
medication may have on student academic and behavioral
performance with and without contingency management
interventions in place (e.g., praise, reprimands,

time

out). These studies strongly indicate that classroom
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interventions can be enhanced with stimulant medication;
however,

to be effective the treatments require thorough

behavioral assessments or functional analyses.
Assessing Stimulant Medication Effectiveness for
Individuals with Mental Retardation
Despite the demonstrated efficacy for treating
hyperactivity in children with ADHD, stimulants are not a
prevalent medication treatment in residential settings for
individuals with developmental disabilities

(Aman & Singh,

1991; Chandler et a l ., 1988). Early studies involving
people diagnosed with mental retardation suggested
stimulant medications were effective in reducing
hyperactivity and improving intellectual functioning and
performance on psychological tasks

(Bell & Zubek, 1961;

Morris, MacGillibary, & Mathieson, 1955). Subsequent
investigations failed to clearly support the therapeutic
efficacy of stimulants

(Aman, 1982; Aman & Singh, 1982;

Berkson, 196 5; Davis, Sprague, & Werry, 1969; McConnell,
Cromwell, Bialer, & Son, 1964; Shafto & Sulzbacher, 1977).
Due to the potential for MPH to precipitate irreversible
tics in hyperactive children with Tourette's disorder and
seizure activity in hyperactive children with autism,
physicians have been cautious in prescribing MPH for
children with developmental disabilities (Klein, Gittelman,
& Quitkin, 1980; Schaal & Hackenberg, 1994).
Most authorities currently agree that the probability
of observing a beneficial stimulant response decreases as
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functional level decreases

(Aman & Singh, 1991). Recent

placebo-controlled studies suggest children with mild to
moderate mental retardation and hyperactivity respond to
stimulants in a manner similar to children with average
intelligence and ADHD (Aman, Marks, Turbott, Wilsher, &
Merry,

1991a). Stimulant medications are the most common

behavior modifying drugs prescribed for individuals with
mild developmental disabilities in special public school
placements to address problems with inattention,
distractibility, and excessive activity that interfere with
learning (Crnic & Reid, 1989; Gadow & Kalachnik,

1981) .

Stimulant medications are not generally recommended for
students with severe or profound mental retardation (Aman &
Singh, 1991; Chandler et al., 1988; Handen & Feldman,
1992).
Proponents of stimulant use with individuals with
severe or profound mental retardation cite the
methodological inadequacies of the early stimulant research
with this clinical population (Aman & Singh, 1991) . The
majority of the drug studies with the developmentally
delayed population omitted (a) basic methodological
features necessary for making conclusions about drug
efficacy (e.g., random assignment of subjects to groups,
placebo control or crossover design, double-blind
observations, and standardized or reliable measurements),
(b)

functional analyses of behavior disorders and/or failed

to control environmental variables,

(c) important
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participant features (e.g., age, gender, other
medications), (d) standardized dose increments, and
(e) objective behavior measures

(Schaal and Hackenberg,

1994). The initial stimulant studies used adult,
institutionalized persons with mental retardation who
exhibited behaviors not typically addressed by stimulant
medications

(Aman & Singh, 1991; Aman et al., 1993b).
Group Efficacy Studies

Recently, a number of sophisticated, large-group
efficacy studies targeted MPH in children with mental
retardation and ADHD or compared CNS stimulants with other
medications

(e.g., fenfluramine,

thioridazine) and

documented positive stimulant responses at efficacy rates
approaching those observed in the average-IQ, ADHD
population (Aman & Singh, 1986; 1991; Handen, Breaux,
Gosling,

Ploff, & Feldman, 1990; Handen et a l ., 1991;

Handen et a l ., 1992). M.G. Aman and colleagues at the
Nisonger Center for Mental Retardation and Developmental
Disabilities at Ohio State University and B.L. Handen and
colleagues in the Department of Pediatrics at the
University of Pittsburgh School of Medicine have initiated
independent efficacy series with MPH and other medications
(thioridazine, fenfluramine) among intellectually
subaverage and developmentally delayed children with ADHD.
Nisonger Center Studies
The Nisonger Center research has targeted (a) the
clinical effects of MPH, fenfluramine, and thioridazine on
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intellectually subaverage children (Aman et al., 1991a),
(b) the cognitive-motor performance of low-IQ children with
ADHD receiving MPH and thioridazine (Aman, Marks, Turbott,
Wilsher, & Merry, 1991b),

(c) the laboratory effects of

fenfluramine and MPH (Aman et al., 1993a) and (d) clinical
and side effects of fenfluramine and MPH (Aman et a l .,
1993b; Aman et a l ., 1997). Overall, Aman and colleagues
found differential effects with MPH in relation to MA, IQ,
and sustained attention. Specifically, MA and IQ may be
important determinants of drug response; higher functioning
individuals with ADHD show a more favorable response to
MPH, and children with lower IQs show an adverse or
indifferent response on both teacher and parent rating
scales (Aman et al., 1991a; 1991b).
The Pittsburgh School of Medicine Studies
The University of Pittsburgh School of Medicine
research team studied stimulant medication use with
children dually diagnosed with mental retardation and ADHD.
Studies targeted MPH (a) efficacy (Handen et a l ., 1990;
Handen et a l ., 1992),

(b) response predictor variables

(Handen, Janosky, McAuliffe, Breaux, and Feldman, 1994;
Handen, McAuliffe, Janosky, Feldman, & Breaux, 1995),
(c) adverse side effects

(Handen et al., 1991), and

(d) efficacy with behavioral interventions on classroom
behavior

(Johnson et al., 1994). Results indicated that

overall drug response rates ranged from 64% to 7 5% but that
a greater number of adverse side effects (e.g., motor tics,
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social withdrawal) were reported in comparison to studies
of children with average intelligence.
Both the Nisonger and Pittsburgh research groups found
effects of MPH with this population that are consistent
with research conducted with children with ADHD but not
diagnosed with mental retardation (Aman et a l ., 1991a;
1991b; 1993a, 1993b, 1997; Handen, et a l ., 1990; 1991;
1992; 1994; 1995). Specifically, children with mental
retardation in the high moderate to mild range and ADHD
appear to respond to MPH at similar rates and in similar
domains to that of the nonretarded population. The MPH
side-effect studies indicated that children with mental
retardation and ADHD may be at a greater risk for
developing these side effects than the nonretarded
population (Handen, et a l ., 1991). In a recent review of
the literature, Aman (1996) concluded (a) children dually
diagnosed with mental retardation and ADHD do respond to
stimulant medication,

(b) stimulant response rate is lower

in children with mental retardation as compared to children
with ADHD and average IQs, and (c) response rate may be
positively related to functioning level

(e.g., IQ, M A ) .

Within-Subject Simulant Efficacy Studies
Most studies evaluating the interactive effects
between medication and specific environmental variables
have used between-group designs that did not control for
environmental contingencies. Poling and Cleary (1986)
recommended applying behavior analysis research strategies
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to clinical psychopharmacology by (a) increasing the use of
within-subject or single-subject designs (e.g., withdrawal,
multiple baseline), and (b) using drugs as independent
variables to determine how drugs affect carefully defined
and measured target behaviors. The few research attempts at
a multimethod approach to stimulant medication evaluations
have the following limitations:
subjective measures

(a) overreliance on

(self-report and rating scales);

(b) limited definitions of the primary problem behaviors
(e.g., academic performance, compliance, inattention); and,
(c) limited clinical observations.
During the 197 0s and 1980s, five methodologically
sound, single-subject studies compared MPH to behavioral
treatments and demonstrated beneficial effects for MPH with
contingency management facilitating appropriate behavior.
(Ayllon, Layman, & Kandel, 197 5; Pelham, Schnedler,
Bologna, & Contreras, 1980; Shafto & Sulzbacher, 1977;
Wulbert & Dries, 1977; Schell et al., 1986). Pelham et a l .,
(1980) found combined drug and behavioral treatment to be
more effective than either component alone. These studies
demonstrated the utility of applied behavior analysis
research in comparing medications to alternative treatments
and in assessing behavioral side effects of pharmacological
interventions.
During the past 10 years, the number of applied
studies demonstrating the utility of single-subject designs
in evaluating the relative and combined clinical
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effectiveness of medication and behavioral interventions
have increased (e.g., Blum et al., 1996; Johnson et a l .,
1994; Shell et a l ., 1986; Stoner et a l ., 1994). Schell et
al.

(19 86) investigated the separate and combined effects

of a behavioral intervention and one dose (0.3 mg/kg) of
MPH on a child with mild mental retardation and found
additive effects of the two interventions on correct
responding to task. Johnson et al.

(1994) used an

alternating treatment, double-blind, placebo-controlled
design with three children with ADHD and mental retardation
and reported differential effects with interventions across
MPH and placebo similar to those reported in single-subject
studies within the average-IQ ADHD population (Northup,
Jones et al., 1997 ; Northup et al., 1999; in press) . Blum
et a l . (1996) used a single-subject experimental
methodology to investigate the separate and combined
effects of behavioral and pharmacologic intervention
concurrently. Behavioral treatments based on functional
analysis have been included in a few stimulant medication
studies

(Cooper et al., 1993; Fisher et al., 1989; Kayser,

et al., 1997; Northup et a l ., 1999; in press).
Environmental Variables in Stimulant Efficacy Studies
Programmed consequences and MPH have demonstrated
efficacy in reducing the disruptive behavior of children
with ADHD. A growing body of research is evaluating the
interactive effects between MPH and environmental variables
(e.g., the behavioral mechanism of the drug action of MPH
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in applied settings). Whalen, Henker, Collins, Finck, and
Dotemoto (1979) used a between-group design to demonstrate
a possible interactive effect between MPH and classroom
antecedent conditions varying by noise level and task
pacing. Wilkison, Kircher, McMahon, and Sloane

(1995) used

a between-group design to demonstrate boys with a diagnosis
of ADHD earned significantly more of a generalized
reinforcer

(pennies) when they received MPH as compared to

placebo.
Northup and colleagues have developed a single-subject
methodology for concurrently assessing (a) the effects of
common classroom contingencies

(e.g., peer attention) and

MPH within a muiltielement design (Northup, Jones et a l .,
1997),

(b) the differential effects for reinforcer

assessments with children receiving MPH and placebo
(Northup, Fusilier, Swanson, Roane, & Borrero,
(c)

1997), and

the separate and interactive effects between common

classroom contingencies

(e.g., timeout, teacher reprimand)

and MPH on disruptive and off-task behaviors

(Northup et

al., 1999; in press).
Blum et al.

(1996) conducted a controlled comparison

of baseline conditions, a behavioral intervention alone,
MPH alone, and a combination of MPH and a behavioral
intervention for the treatment of disruptive behavior in
three children with severe to profound mental retardation.
The primary dependent variable was the percentage of time
engaged in disruptive behavior during a 10-minute task
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session (i.e., placing blocks or books into a specific
container). Engagement with task, defined as the child
picking up or walking with a toy or book in the direction
of the container was also measured. The behavioral
intervention involved differential reinforcement

(DRA) and

guided compliance to decrease the disruptive behavior and
increase task engagement. A forced-choice preference
assessment

(Fisher et al., 1992) was used to identify the

reinforcers used in the differential reinforcement of
alternative behavior

(DRA) procedure. Two of the children

demonstrated decreases in disruptive behavior with
concurrent increases in task engagement in response to MPH.
Three children demonstrated similar improvement in response
to the behavioral intervention. The relative efficacy of
the two interventions varied for the two children
responding to MPH and behavioral treatments. Blum et a l .
(1996) demonstrated the idiosyncratic character of response
to MPH and behavioral treatment in children with severe to
profound mental retardation and recommended both behavioral
and pharmacologic interventions be considered when treating
disruptive behaviors in this population.
Summary
Methodology in the field of psychopharmacology with
the developmentally delayed population has been
historically poor

(Aman & Singh, 1988). Dosage adjustments

have been a problem with both individualized and
standardized regiments commonly used (Aman & Singh, 19 88) .
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The dominant measure of drug response has traditionally
been clinical global impressions; however, recent studies
have relied on direct observations, standardized rating
scales, and tests of learning (Thompson et al., 1993;
Baumeister & Sevin, 199 0).
The basic assumption in behavior analysis is that most
disruptive behaviors are operants sensitive to reinforcing
contingencies. Behavior pharmacology uses single-subject
designs in medication efficacy studies to determine the
effects of pharmacological variables

(e.g., dose) on

behavioral mechanisms of action (Schaal, & Hackenberg,
1994; Baumeister & Sevin, 1990). Behavioral pharmacologists
attempt to determine what are the drug effects on
environmental variables that normally regulate the behavior
of interest. For example, analysts attempt to determine
what environmental contingencies the behavior is naturally
responsive to and determine if any post-medication behavior
change is the result of dose response. Behavior
pharmacology recommend medication studies include a
multidimensional analysis to establish the temporal pattern
and repetitiveness of the target behavior, determine
behavioral or cognitive deficits that might be maintaining
the behavior, and specify the degree the behavior is under
environmental control (Thompson, 1993).
Behavioral pharmacology assesses drug effects on
problem behavior; functional analysis of serious behavior
problems has demonstrated utility with behavior disorders.
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Surprisingly, behavioral treatments based on functional
analysis have been included in only a few medication
studies (Cooper et al., 1993; Fisher et al., 1989; Kayser,
et al., 1997; Northup et a l ., 1999; in press).
The idiosyncratic effect of MPH across behavioral
classes directly impacts which behaviors and measures will
be included in ADHD-stimulant medication studies. Pelham et
a l . (1991) recommends direct observations,

standardized

dose increments, academic performance measures, behavioral
ratings across raters, direct measures of behavioral change
to determine dosage effects, measures of social validity,
and convergent validity of observational measures with data
from other sources. Although single-subject methodology can
easily be adapted to meet these goals, most medication
studies have used between-group designs and used direct
observations as supplementary rather than primary measures
(Gulley & Northup, 1997).
Many group studies with children with ADHD and average
IQs have combined medication and behavioral treatments. The
general consensus of these studies is that behavioral
treatments in combination with low doses of MPH are more
effective than either intervention alone for children with
ADHD and average intelligence (Carlson, Pelham, Milich, &
Dixon, 1992; Pelham Milich, & Walker, 1986). The degree to
which these group studies are able to reflect the response
of individual children to these interventions is not known.
Blum et al.

(1996) used a single-subject experimental
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methodology to investigate the separate and combined
effects of behavioral and pharmacologic intervention
concurrently and found no evidence of an additive or
synergistic effect of the two interventions; no studies
have used have used functional analysis to determine
effective behavioral and medication treatments or
investigate the separate and combined effects of these
treatments.
MPH has established efficacy in average IQ and mild
disability populations for the treatment of disruptive
behaviors in educational and training settings. It would
appear to be an appropriate choice in a medication efficacy
study comparing medication status and function-related
intervention with clinically significant disruptive
behaviors.
Treatment prevalence studies have shown psychotropic
and anti-epileptic drugs are prescribed frequently in the
mental retardation population (Aman & Singh, 1988; Aman,
Sarphare, & Burrow, 1995). Traditionally,

lower IQ, adult,

and institutionally placed individuals with disruptive
behaviors have been treated with medications that have
dangerous side effects

(e.g., neuroleptics,

antiepileptics). Stimulant medication has been infrequently
used among individuals with mental retardation, especially
in residential facilities

(Aman & Singh, 1991). In contrast

to other drugs commonly used to control disruptive
behaviors in the mental retardation population, MPH has
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virtually no long-term side-effects. Stimulant medications
have been considered too short-acting (e.g., half-life of 2
to 3 hours)

to meet the long-term and 24-hour needs of

these individuals. Recent research showing positive effects
has rekindled interest in stimulant medications to control
disruptive and destructive behaviors in individuals with
severe to profound mental retardation.
Purpose
The purpose of this study was to demonstrate the
utility of a single-subject design and functional analysis
in determining the separate and combined effects of
short-action stimulant medication and behavioral treatments
with disruptive behaviors of persons with severe to
profound mental retardation. This study developed an
individualized, comprehensive assessment of medication
effects that includes multiple behavior measures in a
variety of settings to determine (a) an optimal dose, if
any, of stimulant medication,

(b) differential medication

effects at various doses and across various target
behaviors,

(c) changes in academic or training performance

and care provider ratings in relation to child behavior,
and (d) separate and combined effects of stimulant
medication and behavioral treatments on the disruptive
behavior and task engagement of children with severe to
profound mental retardation.
This study extended single-subject stimulant
medication efficacy research within the ADHD population by
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(a) targeting children in the severe to profound range of
mental retardation,

(b) evaluating individual MPH effects

on academic or training tasks unique to this population,
(c)

including a functional analysis assessment component,

and (d) analyzing the individual separate and combined
effects of mediation and behavioral treatments on
disruptive behaviors and task engagement.
This study extended previous MPH-efficacy studies
within the mental retardation population by (a) using
multiple assessments of different behaviors conducted in a
variety of settings in a single-subject design,
(b) exploring the utility of analog functional analysis in
drug and behavioral treatments for disruptive behaviors and
task engagement of children diagnosed with severe to
profound mental retardation, and (c) evaluating
drug-behavior interactions

(i.e., possible behavioral

mechanism of drug actions).
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METHOD
Participants
Five children, ages 10 to 15, with severe to profound
mental retardation participated in this study. All children
engaged in severe disruptive behavior and resided in a
private, Intermediate Care Facility for Mental Retardation
(ICF-MR). Inclusion criteria required that each child
(a)

have a current Diagnostic and Statistical Manual of

Mental Disorders-IV (DSM-IV) diagnosis of Mental
Retardation (severe to profound range), (b) display
referral behaviors considered to be harmful to self or
others or to significantly interfere with training or
educational development,
(d)

(c) be between ages of 6 and 18,

have a physician recommendation for a trial of

methylphenidate

(MPH), and (e) have signed authorizations

from the facility, prescribing physician, and parents or
legal guardians consenting to the participation in a
medication evaluation to identify the therapeutic dose, if
any, of MPH for optimal functional training and social
behavior. Demographic information for the children is
provided in Table 2.
Cade was a 12-year-old, white male who had resided at
the facility for six years. He called out words and phrases
(go on the bus, missing toys, find the toys) disruptively
in the classroom. He followed simple commands (sit down,
stand up, bring) and knew his daily routine.
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Cooper was a 10-year-old black male, who had resided
at the facility for six months. He could recite the
Table 2. Participant Demographic Information
Diagnosis
Medication
Behaviors
Name
Age
Cade

12

MR-Profound
Self-injurious
behavior (SIB)

None

Hyperactivity
Out of seat
Calls out
Twirls in circles
Hand/finger play
Head bangs wall
Wrist/elbow hits

Cooper

10

MR-Severe
Hyperactivity

None

Hyperactivity
Runs away
Pinches
Screams
Plays with toilet

Frankie

12

MR-Profound
Overactivity

None

Hyperactivity
Throws objects
Out of seat
Grabs glasses
Destroys property
Noncompliance
(flops to ground;
verbal refusal)
Disrobes

Joel

15

MR-Severe
Hyperactivity

None

Body rocks
Runs away
Calls out
Tantrums (cries,
rolls on floor)
Hits knees, hands
on floor
Throws objects

Mark

13

MR-Severe
Hyperactivity

None

Hyperactivity
Distractable
Excessive talking
Hits, kicks,trips
Runs away
___________ Destroys property

alphabet and say his name and some words, but he rarely
spoke. He vocalized loud noises in the classroom and
laughed when corrected. He could copy the numbers 1-10 and
the alphabet, count to 20, and identify shapes. His
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academic performance was generally contingent on one-to-one
staff attention. He would throw paper in the air, overturn
his desk, or make disruptive noises if the aide left his
side.
Frankie was a 12-year-old, white female who had
resided at the facility for six years. She was marginally
verbal, and communication was restricted to inconsistent
gestures
words

(point, wave, smile, head shake), vocals, some

(ball, eat, mama), and signs (toilet, eat). Although

capable of performing many self-help tasks, Frankie usually
waited on others to dress and toilet her. She required
one-to-one supervision and engaged in disruptive behaviors
harmful to herself or others if ignored (e.g., pulling on
electrical cords, appliances, throwing herself on the
ground), property destruction (pulling papers from walls,
throwing objects), or aggression (throwing objects at
people, pinching, pulling or pushing). For example, prior
to be being included in this study, Frankie had broken her
arm by throwing herself on the side of a concrete side
walk.
Joel was a 15-year-old, white male who had resided at
the facility for nine years. He was marginally verbal
(mommy, bye, dada, wawa, coke, baba, eat). He communicated
his needs by pointing, vocalizations, and some functional
signs. He responded to his name, identified common
environmental objects by pointing, and followed most simple
commands. He exhibited stereotypies (body rocking, twirling
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objects in his hands). A preferred item was a clear plastic
bottle, and he would throw himself on his knees and slam
his hands on the floor when his teacher or support workers
removed the bottle to engage him in a training activity.
Mark was a 13-year-old, black male who had lived at
the facility for 4 years. Mark was verbal, spoke in short
sentences, and repeatedly sought adult attention. For
example, he would inappropriately recruit attention by
calling out in class (Is this right?. Come see?. Hev. did I
do good?) . Ignoring him usually resulted in his leaving his
seat and engaging in disruptive, attention-seeking
behaviors

(arm pats and tugs, repetitive verbal requests,

opening the teacher's desk, tripping a peer, and destroying
property).
Signed informed consent forms were obtained from the
parents or legal guardians (Appendix A ) . In addition,
approval for this study was obtained from the facility's
Human Rights Committee. A written description of the
assessment was provided to the prescribing physician and a
signed agreement to participate was obtained.
Settings and Materials
The preference assessments and analog analyses were
conducted at the residential facility in a training room
equipped with a one-way observational window and intercom
with no peers present. Medication and intervention
observations were conducted in self-contained classroom
settings unless the teacher indicated the session might be
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disruptive to some on-going activity. Each self-contained
classroom housed 6 to 8 students, the teacher, and two
aides. Due to the normal flow of school activities,

the

number of students and professional staff in the classroom
varied during the observation.
In analog assessments, the child was seated with an
individualized task or preferred toys at a table. When
assessed in the classroom,

the child was seated either at a

desk or a table located to the side or back of the
classroom. For one child (Frankie), who threw blocks during
the assessment procedure, some classroom observations were
conducted with a partition (5 by 8 feet) separating her and
the other children.
Response Definition and Measurement
Independent Variables
Medication Status
The primary independent variable was medication status
at placebo, low (0.3 mg/kg), moderate (0.6 mg/kg), and high
(0.9 mg/kg) dose of MPH. The physician initially prescribed
a placebo and a low dosage of MPH and titrated upward if
indicated. Cade received placebo and two dose levels of MPH
(5, 10 m g ) . Cooper, Joel, and Mark received placebo and two
dose levels of MPH (10, 15 m g ) . Frankie received placebo
and three dose levels of MPH (5, 10, and 15 m g ) .
Behavioral Interventions
Secondary independent variables were the behavioral
treatments that were developed for each child based on the
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prior functional analysis. Behavioral treatments were
evaluated both alone and in combination with MPH to
determine the effectiveness of a behavior intervention as
an alternative to MPH and the maximal effectiveness of the
combined treatments. The behavioral treatment involved
differential reinforcement of appropriate behavior
following a verbal prompt or model with graduated
compliance to

complete the task. The child earned a

reinforcer if

he or she performed the task following the

verbal request or model. A time out procedure was used with
three of the children if a disruptive behavior occurred
during the task.
Dependent Variable and Response Definitions
The primary dependent variable was the percentage of
10-second intervals the child engaged in disruptive
behavior. Specific targeted disruptive behaviors were
determined by

individual referral concerns and

pre-assessment classroom observations, and
following:

(a) inappropriate vocalizations

included the
(any vocal sound

or verbalization disruptive to the situation, not preceded
by the child raising his or her hand), (b) playing with
objects

(touching any object that was not part of the

assigned educational or training task), (c) out-of-seat
behavior

(full body weight not supported by chair or the

child's buttocks being removed from the chair for longer
than 3 seconds),

(d) aggressive behavior

(e.g., hitting,

slapping, biting, kicking, pinching, scratching, pushing
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others and throwing/pushing objects), (e) repetitive,
nonfunctional behaviors injurious to self (e.g., hitting,
slapping, biting, pinching, scratching self) or disruptive
to training or educational task (e.g., hand or finger
gazing/playing, body/head rocking), and (f) resistive or
refusal behaviors

(e.g., pushing material away, verbal or

gestural refusal, turning body or head from task).
Other dependent measures were task engagement, and
scores from the behavior rating and side-effect scales.
Task engagement was defined as the percentage of intervals
in which the child touched, picked up, or walked with a
task material in the direction of the work site (e.g., held
a pencil, turned his paper over). Engagement was coded from
the onset of the behavior until disengaged for 5 seconds.
Engagement was not coded if the child exhibited disruptive
behaviors or was placed in time out.
Data Collection and Reliability
Data collected included (a) the percentage of
intervals in which disruptive behaviors occurred,
(b)

percentage of intervals in which the child was task

engaged,

(c) productivity or the amount of academic work

completed,

(d) accuracy or the percentage of work completed

correctly, and (e) the integrity of the assessment
condition or intervention (percentage of target responses
followed by correct therapist response).
All child responses were manually recorded using a
10-second partial interval recording procedure with a tape
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recorder signaling each interval during 10-minute sessions.
A second observer independently recorded data
simultaneously with a primary observer to establish
interobserver agreement. Observers were required to
complete the following training procedures:

(a) average at

least 90% agreement with previously trained observers
during two videotaped sessions, and (b) train in vivo with
an experienced graduate student until the trainee averaged
at least 9 0% agreement with previously trained observers.
In all cases, interobserver agreement was calculated
on an interval-by-interval basis for each response
definition by (a) dividing the session into consecutive
10-second intervals,

(b) dividing the number of agreements

(occurred/did not occur during the interval) by the sum of
agreements and disagreements and multiplying by 100%, and
(c) averaging that number across sessions

(Kazdin, 1982).

Interobserver agreement was assessed during 30% of all
sessions

(range 20% to 67%) for each child. Interobserver

agreement was obtained on an average of 32% (range, 25% to
50%) for Cade, 35% (range, 20% to 50%) for Cooper, 29%
(range, 25% to 33%) for Frankie, 30% (range, 20% to 67%)
for Joel, and 35% (range, 25% to 67%) for Mark.
Interobserver agreement exceeded 9 0% for all dependent
variables. Table 3 presents interobserver agreement for
each child across all conditions.
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Table 3. Percentage of Interobserver Agreement across
Conditions
Cade Cooper Frankie Joel Mark
Phase 1 Condition
Attention
100
91
96
96
99
Alone
98
99
96
96
98
Control
98
99
100
100
99
Demand
94
98
100
99
96
97
Tangible
N/A
N/A
99
99
Total (Phase 1)
98
95
98
98
98
Phase 2 Conditions
Attention
98
99
97
98
99
No Interaction
99
99
98
97
98
Total (Phase 2)
98
99
97
98
99
Phase 3 Conditions
MPH
100
98
98
N/A
N/A
MPH plus BI
99
99
98
N/A
N/A
97
BI
98
95
100
98
97
BI plus Placebo
99
96
N/A
N/A
Total (Phase 3)
98
97
98
100
98
Procedural Integrity
Child and therapist behaviors were observed to assess
the degree to which intervention sessions were conducted as
intended. The therapist (experimenter) behaviors of toy
presentation, demands, time out, tangible deliverance, and
attention were recorded during relevant conditions to
ensure the procedural integrity of all sessions. Demands
were defined as the first verbal instruction provided
during a three-prompt instructional sequence from the
therapist directed toward the child. Compliance was scored
when the child completed the instruction after the initial
vocal or modeled prompt. Time out was defined as removal of
work materials and therapist attention during a 10-second
interval. Tangible delivery was defined as the therapist
providing the child access to preferred toys during a
10-second interval. Attention was defined as the therapist

59

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

providing the child with a brief vocal reprimand, praise,
and/or physical contact during a 10-second interval.
Procedural integrity was calculated by two methods in
all sessions for each child. First, integrity was
calculated as a percentage of target behaviors that were
followed by the therapist responses specified for each
assessment condition or intervention, and the nonoccurrence
of any other dependent variable during the same or
subsequent 10-second interval. Second, a percentage of
intervals was calculated for the occurrence of intervention
independent variables that were not contingent upon a
target behavior, in order to indicate experimental control.
Procedural integrity during analog and classroom functional
analysis sessions averaged 96% for all conditions

(range

90% to 100%) and 96% for all children during the treatment
analyses

(range 90% to 99%) .
Rating Scales

Teachers and direct support workers (DSWs)completed
daily behavior rating scales when the child received
medication or placebo. The scales were based on the School
Situation Questionnaire-Revised,

the Home Situation

Questionnaire-Revised, the Child Attention Profile, and the
Side Effects Rating Scale (Barkley, 1990). The Intervention
Rating Profile-15

(Martens, Witt, Elliott, & Darveaux,

1985) was administered prior to treatment and at the end of
the study. The authors of these scales have given
permission to duplicate or alter these scales for clinical

60

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

or research purposes. The Child Attention Profile and the
Side Effects Rating Scale were retyped on separate pages
and retitled, Behavior Rating Scale. Written instructions
directed the rater to mark the items as they applied to the
child's behavior that day. Two versions of the Intervention
Rating Profile-15 were used to obtain pre- and
post -treatment ratings from teachers and direct support
workers. A description of the scales follows.
The Child Attention Profile (CAP)
The CAP is a 12-item scale developed to measure
inattention and overactivity (Barkley, 1991) and is
frequently used in stimulant drug efficacy studies
(Barkley, 1990). The child's behavior is rated on a 3 -point
Likert scale ranging from 0 (not true)

to 2 (very or often

true). Five items loading on the overactivity scale and the
seven loading on the inattention scale were chosen to
create a brief instrument to assess stimulant drug effects.
Higher CAP scores (84 to 108) correspond with severe levels
of inattention and disruption. Mid-range scores

(37 to 83)

indicate moderate problems and lower scores (0 to 36)
indicate mild to no problems with inattention and
disruption.
The Home Situations Questionnaire-R (HSO-R)
The HSQ-R is a 14-item scale that assesses specific
problems with attention and concentration across a variety
of home and public situations (Barkley, 1991). The primary
support worker first endorses all items as Yes or No and
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then rates Yes items for severity on a 9 -point Likert scale
from 1 (mild) to 9 (severe). The scale yields scores for
the number of problem settings (e.g., alone, with children,
at meals) and an overall problem severity score. Higher
HSQ-R scores

(98 to 126) correspond with severe levels of

inattention and poor concentration in home situations.
Mid-range scores

(48 to 97) are associated with moderate

levels of inattention, and lower scores

(0 to 47) indicate

mild to no problems in these areas.
The School Situations Questionnaire-Revised (SSQ-R)
The SSQ-R is an 8-item scale assesses specific
problems with attention and concentration across a variety
of school settings (Barkley, 1991). The teacher or aide is
asked to indicate whether the child displays behavior
problems in each of 8 common educational settings. The
rater first endorses the items as Yes or No and then rates
Yes responses for severity on a 9 -point Likert scale from l
(mild)

to 9 (severe). The scale yields a score for the

total number of problem settings and an overall problem
severity score. Higher SSQ-R scores

(56 to 72) correspond

with severe levels of inattention and poor concentration in
home situations. Mid-range scores (32 to 55) are associated
with moderate levels of inattention and lower scores

(0 to

31) indicate mild to no problems in these areas in the
home.
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Side Effects Rating Scale
The Stimulant Drug Side Effects Rating Scale

(SDSERS;

Barkley, 1990) is a 17-item, 9 -point Likert scale ranging
from 0 (absent) to 9 (serious) that is used to report
whether the individual is experiencing common side effects
(e.g., headaches, stomachaches, insomnia) associated with
the use of stimulant medication. The scale was retyped and
titled, Behavior Scale. Four additional items were included
(i.e., mood changes quickly, hostile/angry,
nervous/anxious, and agitated)

to assess side-effects in

individuals with profound and severe developmental delays.
Higher SDSERS scores (147 to 189) correspond with severe
levels of observed MPH side effects. Mid-range scores

(64

to 146 are associated with moderate levels of MPH side
effects and lower scores (21 to 63) indicate mild levels to
no observed problems. Side-effect scales were reviewed
daily for individual items and a total side effects score
was obtained by averaging daily ratings across all items
for each child.
The Intervention Rating Profile-15
The Intervention Rating Profile-15

(Martens et al.,

19 85) is a 15-item survey with items scored on a 6 -point
Likert scale ranging from strongly disagree to strongly
agree. Scores range from 15 to 90 with higher scores
representing greater acceptability. The purpose of the
questionnaire is to obtain information about the care
provider's reaction to a proposed or completed intervention
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(Witt and Martens, 1983). In this study, Two questionnaire
versions were used to determine factors that may be related
to the use of the medication or behavior interventions. The
Behavior Intervention Rating Form evaluated the teacher and
support worker's assessment of the acceptability of the
behavior interventions used in this study prior to and
following implementation. The Medication Intervention
Rating Form assessed the teacher and support worker's
opinions regarding the acceptability of a medication
intervention prior to and following the medication
evaluation.
Design
All functional analysis conditions were conducted in a
single-subject multielement or alternating treatment
design. All medication evaluations were conducted in an
alternating treatments design in which each dosage of MPH
randomly alternated with a placebo. After an optimal dosage
of MPH was determined for three of the children, behavioral
interventions were randomly alternated with MPH, a placebo,
or no pill.
Procedures
Phase 1: Preference Assessment and Functional Analysis
Preference Assessment
Potential reinforcers for the functional analysis were
identified for each child in free operant preference
assessments based on procedures developed by Roane,
Vollmer, Ringdahl, and Marcus

(1999). The preference
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assessments were used to identify potential reinforcers
that could be used during the functional analysis and/or
incorporated into behavior interventions

(phase 3). For

each child, 10 stimuli were included in the assessment.
Preference assessment stimuli were selected based upon
teacher or support worker report, the child's endorsement
(if verbal), and preassessment observations. Assessments
were conducted in an empty observation room with
observations made through a one-way window. Prior to each
assessment, stimuli were presented individually for 45
seconds. Then, the 10, equally spaced, stimuli were
presented concurrently on the floor. The children were free
to ignore all items or interact with any of the items
individually or collectively during the session. No items
were removed during the assessment. Each child was exposed
to a minimum of two 5 -minute sessions. All contact between
the child's hands or fingers with a stimulus item were
scored using a 10-second partial interval recording method.
Each 5 -minute session was divided into 30, 10-second
intervals. The percentage of partial 10-second intervals in
which the child manipulated each stimulus was divided by
the total number of intervals and multiplied by 100 to
yield a preference index per item. One to three stimuli
with the largest index of preference were considered for
use in the functional analysis.
Table 4 presents the preferred items identified during
the free-operant assessments for each of the children. The
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primary preferred item was also used in the subsequent
academic and behavioral interventions developed for Joel
and Mark.
Table 4. Preference Assessment Indexes for Each Child
Child
Items
Preference Index
Frankie
67%*
Person (social interaction)
Favorite song on cassette
37%
Toy Guitar
33%
Cade
Person (social interaction)
3%
Cooper
Waterfall tube
100%
Mark
Toy guitar
82%
Social interaction
35%
Radio
33%
Joel
Plastic bottle
52%
Person (social interaction)
20%
Pen and paper
18%
* Frankie sat in person's lap and manipulated toys.
Functional Analvsis
The functional analysis was based on procedures
described by Iwata et al.,
and Northup et al.

(1994/1982), Sasso et al.(1992),

(1999, in press). The analog analysis

was conducted by the therapist in a room with a one-way
observation window. The classroom functional analysis was
conducted by the therapist in the class or training room.
During the functional analyses, each child was exposed to
four to six experimental conditions (escape, attention,
tangible, alone, control, and no interaction). Five trained
therapists conducted the sessions wearing shirts
color-coded for each condition. When possible,

the same

therapist conducted all sessions across that condition for
the child. Table 5 describes the training task and
materials used in the attention, tangible, alone, and no
interaction conditions for each child.
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Table 5 , Instructional Tasks and Materials
Materials
Task in Attention, Alone,
Child
No Interaction, Tangible

Task in
Demand

Materials

Frankie

Shape discrimination
and sorting

Playskool 8" x 8" cube
18 insertable forms

Discrimination

4 shapes
5 containers

Cade

Shape discrimination
and sorting

Playskool 8" x 8" cube
18 insertable forms

Discrimination

4 shapes
5 containers

Cooper

3 Copy worksheets

Name model, 10 copy lines
1-10 model, 10 copy lines
A-L model, 10 copy lines

Discrimination

4 shapes
5 containers

Mark

Color sheets

Bunny on 8fct" x 11" paper
Jumbo crayon

Discrimination

4 shapes
5 containers

Joel

Three-piece
bolt-set assembly

3 assembly trays
15 3 -inch bolts
15 washers, nuts

Discrimination

4 shapes
5 containers

Demand condition. Instructional tasks were similar to
those presented in the child's educational or training
environment, but were identified as difficult (i.e., less
than 7 0% accuracy in previous trials). A graduated,
three-prompt sequence was used to present instructions
(Horner & Keilitz, 1975). The therapist (a) verbally
requested the child to perform a task,

(b) modeled

compliance with the instruction following five seconds of
noncompliance with the verbal request, and (c) physically
guided the child (hand over hand)

to comply with the

instruction after five seconds of noncompliance with the
modeled request. Praise was delivered contingent on a
correct response following the first or second request. The
three-prompt, demand sequence trial was completed at
pre-set intervals

(15 to 30 seconds) dependent upon the

identified performance rate of the child. Occurrence of a
targeted disruptive behavior resulted in termination of the
instruction trial for 30 seconds. Thus, the child escaped
the demand sequence or task contingent through a target
response (e.g., aggression). The purpose of this condition
was to test for behavioral responsiveness to escape as a
reinforcing consequence.
Attention condition. During this condition,

the child

was seated at a table with a training task that could be
completed with 7 0% to 90% accuracy following an initial
instruction and model (e.g., assembling bolt-washer-nut
units). The therapist gave the initial instruction (e.g.,
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Sit cruietlv and put these together) , moved away from the
child, and appeared to be busy and not attending to the
child. The therapist only attended to the child to deliver
statements of concern or reprimands following each target
response. The purpose of this condition was to determine
responsiveness of the target behavior to positive
reinforcement in the form of attention.
Materials or tangibles condition. This condition was
included for children who exhibit a targeted behavior when
preferred stimuli were blocked or withdrawn. The preferred
stimulus was exposed to the child for 2 minutes prior to
the session. The stimulus was removed from reach but
remained visible once the session began. The child was
seated at a table with the same training task and initial
instruction used in the attention condition. The therapist
monitored the task while walking about the room. The
therapist made the preferred stimulus available to the
child for 30 seconds contingent upon a target response.
When the target behavior occurred, the therapist
immediately moved the preferred stimuli to the side of the
table within reach of the child for 30 seconds, and removed
the stimuli to the initial position after allowing 30
seconds of access. The purpose of this condition was to
determine responsiveness of the target behavior to positive
reinforcement in the form of tangible stimuli.
Alone condition. During this condition,

the child was

alone in a room with a one-way observational window. All
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neutral stimuli were removed. The child was seated at a
table with the same training task described in the
attention and materials conditions. The therapist left the
room after placing the task on the table and delivering the
instruction. No programmed consequences were provided for
any targeted behavior, and no interaction occurred between
the therapist and the child. The purpose of this condition
was to determine if the target behavior would persist
independent of social consequences in a relatively barren
environment.
Plav (control) condition. During this condition,

the

child was seated at a table with a preferred task or toy
(e.g., radio, musical instrument). The therapist sat at the
table with the child and provided attention (praise,
conversation, pats or rubs to arms or back) on a
differential reinforcement of other behavior

(DRO) schedule

with a mean inter -reinforcement time (IRT) of 15 seconds
and no programmed consequences for a target behavior. The
schedule of reinforcement delivery varied for each child
dependent upon his or her current disruptive behavior rate.
This condition served as a control condition in that the
child had access to attention and there were no
instructional demands to complete the task during the
session (Iwata et a l ., 1994/1982).
No interaction (ignore) condition. The child was once
again seated at his desk in the classroom with the same
training task used in the attention, tangible, alone, and
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play conditions. The therapist walked about the room
ignored all appropriate and inappropriate behavior, and
delivered no attention. This condition is similar to the
alone condition but assesses the effects of the presence of
a noninteracting adult or class peers on the disruptive
behavior.
Phase 2: Medication Evaluation
General Procedures
Following the initial functional analysis,

10-minute

baseline probes were conducted in the classroom using the
two functional analysis conditions in which the highest
levels of target behavior were exhibited. The children were
then observed in one-day (low dose) or two-day (medium or
high dose) blocks while receiving placebo or MPH, once each
morning and afternoon for 4 days (low dose) or 8 days
(medium or high dose). All behavioral observations were
conducted at the same time daily in the classroom while the
child completed a task supervised by the therapist.
Observations were made 1 to 2 hours after administration of
either medication or placebo.
The purpose of the classroom analysis was to determine
the effects of medication status on disruptive behaviors in
academic or training settings under two controlled
environmental conditions (e.g., no interaction or
attention)

for which analog functional analysis effects had

been previously demonstrated.
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Phase 3: Behavioral Intervention
Phase 3 was designed to evaluate the effects of
different treatments in reducing disruptive behavior and
increasing task engagement in the following treatment
conditions: behavioral intervention alone, behavior
intervention plus placebo, MPH alone, and MPH plus behavior
intervention. This phase compared the effects of MPH and a
function-related behavioral intervention alone and together
in effectively reducing disruptive behavior and increasing
task engagement for the children identified as MPH
responders. For the children who were non-responsive to
MPH,

this condition evaluated whether a function-related

intervention would effectively reduce the target behavior
while concurrently increasing task engagement.
Intervention Development
In general, the behavioral intervention was based on
removing or interrupting the environmental contingency
associated with the highest levels of inappropriate
behavior and, whenever possible, providing the same
reinforcement for appropriate behavior; however, as the
functional analysis indicated high levels of disruptive
behavior during the alone condition for all children, a
variety of antecedent manipulations were also included in
the behavior intervention. For some of the children,
assessment observations indicated the task or task
presentation could be altered to better meet the child's
current functional level or increase overall task
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performance. Whenever a functional analysis condition was
associated with increased task engagement or reduced levels
of disruptive behavior, essential components of that
condition were included in the intervention. For example,
disruptive behavior decreased and task completion increased
during the demand condition for all participants. Thus, a
DRA with graduated compliance procedure was modeled on the
three-prompt, demand sequence (prompt, model, graduated
compliance). For Mark and Joel,

the items used during the

materials or tangible condition were incorporated with the
DRA for functional communication training.
Ca d e . Cade's task was to correctly place a square,
triangle, and circle from left to right in a large form
board with generalization to similar tasks

(i.e., a

smaller, similar form board, Formfitter cube used in the
initial analysis). An analysis of the shape sorting task
was conducted and differential reinforcement with graduated
compliance in a three-prompt sequence (verbal prompt,
model, graduated compliance) was selected to train the
concept of putting in the multiple shapes. Stereotypies
that were neither task disruptive nor precursors to more
serious SIB were ignored. Verbal interruption (No) with a
5 -second basket hold was the intervention for head banging,
striking wrist or elbow with objects and pre-SIB
stereotypies

(elevated arm and hand posturing that preceded

elbow and wrist strikes). The procedure also had an escape
extinction component that prevented escape from the task.
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The basket hold was followed by re-presenting the task
using the hands down and get ready intervention in his
current IEP. The therapist would release Cade from the
hold, and say, "Hands down, get ready", guide Cade's hands
to midline on the table, and restart the task. The brief
time out was used only with behaviors that had been
observed to precede to self-injurious behaviors

(head or

elbow hitting). It was gradually faded to a verbal prompt
(hands down, get ready) .
Cooper. Cooper's academic task involved verbally
identifying letters presented in a Curriculum Based
Measurement

(CBM) format. Previous observations indicated

Cooper would disrupt the learning task by leaving his seat
and disruptive behavior would increase when verbally
corrected. Pats to the back or arms and extended verbal
praise directed to Cooper resulted in loud disruptive
laughing, call outs, or aggressive behavior toward the
teacher. Thus, the academic setting was rearranged to limit
physical contact, and the need to verbally reprimand out of
seat behavior. The therapist was seated to the left and
slightly behind Cooper at a table, and Cooper's right side
was immediately next to the wall. Cooper could escape the
task only by sliding under the table.
Differential reinforcement with graduated compliance
in a three-prompt sequence was selected to train the task.
A 30-second time out was the intervention for disruptive
behavior. The therapist would point at a letter with a
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pencil, and say "This is

If there was no response in

3 seconds, he would put Cooper's finger on the letter and
say "This is

If there was no response in 3 seconds,

he would put Cooper's finger on the letter and say "This is
a ___ ". Compliance on step one or two earned a one-word,
praise statement

(Good). The therapist removed the task and

turned away for 30 seconds when a disruptive behavior
occurred (time out). At the end of the time out period,
Cooper was returned to his chair and the first prompt was
presented again.
Frankie. Frankie's academic task was identical to
Cade's except for the forms used in the large form board.
Frankie's forms were made of cardboard and packing tape for
noise reduction and to reduce the possibility of injury to
others when the forms were thrown. Frankie's behavioral
intervention used alternate seating, differential
reinforcement with graduated compliance, and a 3 0 -second
time out with an in-seat requirement. The therapist removed
the task and attention for 30 seconds when a disruptive
behavior occurred. During the time out, the therapist
averted his face and positioned his arm and shoulder to
block her efforts to pull his hair and scratch his face and
used his leg to secure her chair. The therapist continued
to present commands at 5- to 10-second intervals and
provide praise (good job) for successful attempts when no
disruptive behavior occurred. In order to limit her
opportunities to misbehave, the table was placed beside the
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wall,

the therapist's chair was positioned slightly behind

Frankie, and the therapist removed glasses and other
breakable items and wore long sleeves to protect his arms
during the time out.
J oel. A task analysis of existing class rules was
conducted to train the concepts of in-seat behavior, hand
signaling for attention, waiting, and appropriate
requesting. Differential reinforcement in the form of
functional communication training (FCT) with graduated
compliance was used to train Joel to say baba and signal
with his hand to access a clear plastic bottle. After
giving Joel 1 -minute access to the bottle, it was removed,
and he was trained to raise his hand to recruit the
therapist's attention, wait appropriately in increments

(5,

10, 15, 20, 30 seconds), until a timer signaled the end of
the interval, and then appropriately sign for the bottle
when asked, "What do you want?" Behavioral interventions
included a three-prompt sequence to manage out-of-seat
behavior, verbal interruption for loud talk-outs, and
ignoring all quiet self-talk or movements not disruptive to
the task.
Ma r k . Mark's academic task was identical to Joel's.
Differential reinforcement with graduated compliance was
used to train Mark to appropriately signal for attention
(How do you ask?), verbally request his toy guitar
you want?), and wait appropriately in increments

(What do

(5, 10,

15, 20, 30 seconds) until a timer signaled the end of the
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wait interval. Behavioral interventions included guided
compliance to manage out-of-seat behavior, verbal reprimand
for loud talk-outs, and ignoring all quiet self-talk or
movements not disruptive to the task.
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RESULTS
Phase 1: Functional Analysis
Figure 1 shows the results of the functional analysis
for Cade (upper panel) and Frankie (lower panel) and figure
2 shows the results for Joel
panel) and Cooper

(upper panel), Mark (middle

(lower panel). For all children, data are

plotted as the percentage of intervals of disruptive
behavior

(e.g., calling out, throwing or tearing objects,

leaving seat, hitting, kicking, or pinching others,
throwing or tearing objects, hitting self) across sessions.
For Cade, disruptive behavior occurred at high and
stable levels during the alone condition (mean, 94%; range,
90% to 100%). Relatively low levels of disruptive behavior
occurred during the attention condition (mean, 4%; range,
2% to 7%). No disruptive behavior occurred during the
demand condition and low levels were recorded during the
control condition (mean, 2%; range, 0% to 3%). Based on
these results, Cade's disruptive behavior did not appear to
be maintained by socially-mediated reinforcement.
For Frankie, disruptive behavior occurred at high and
stable levels during the alone condition (mean, 93%; range,
83% to 100%). Moderate and stable levels of disruptive
behavior occurred during the attention condition (mean,
39%; range, 27% to 48%). Disruptive behavior was reduced in
the demand condition (mean, 12%; range, 3% to 25%) and in
the control condition (mean, 1%; range, 0% to 4%). Thus,
the results for this analysis suggested that disruptive
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Figure 1. Percentage of intervals of disruptive behavior
across functional analysis conditions (alone, demand,
control, attention) for Cade (upper panel) and Frankie
(lower panel).
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Figure 2. Percentage of intervals of disruptive behavior
across functional analysis conditions (alone, attention,
control, demand, tangible) for Joel (upper panel), Mark
(middle panel), and Cooper (lower panel).
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behavior was most likely related to socially mediated
reinforcement in the form of attention or some unknown
variable associated with the alone condition.
For Joel, disruptive behavior occurred at high levels
in the alone condition (mean, 78%; range, 52% to 93%),
relatively low but variable levels in the attention (mean,
6%; range, 0% to 12%), tangible (mean, 7%; range,

0% to

22%), demand (mean, 1%; range, 0% to 2%), and control
(mean, 6%; range, 0% to 23%) conditions. Based on these
results, Joel's disruptive behavior did not appear to be
maintained by socially-mediated reinforcement.
For Mark, disruptive behavior occurred at high levels
in the alone condition (mean, 81%; range, 58% to 9 3%) and
moderate levels in the attention (mean, 26%; range, 25% to
28%) and tangible (mean, 16%; range, 14% to 19%)
conditions. Disruptive behavior levels were low and stable
in the demand (mean, 1%; range, 0% to 2%) and control
(mean, 0%) conditions. These results indicated the
disruptive behavior was highest in the alone condition but
was also responsive to socially mediated positive
reinforcement in the form of attention and tangible items.
For Cooper, disruptive behavior was high and stable in
the alone condition (mean, 96%; range, 90% to 97%) and
attention condition (mean, 86%; range, 77% to 97%).
Disruptive behavior was moderate to high during the demand
(mean, 39%; range, 6% to 65%) and tangible (mean, 57%;
range, 50% to 71%) conditions, and low and stable during
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the control condition (mean, 10%; range, 0% to 18%). Thus,
the results for this analysis might be considered either
multiple controlled or undifferentiated. The level of
disruptive behavior was highest in the alone condition, was
responsive,

to a lesser degree, to positive reinforcement

in the form of attention or tangible items, and remained
low during the control condition.
Table 6 shows the task performance results for all
children during the demand, attention, and alone
conditions.
Table 6. Analog Performance Measures across Conditions
Measures
Demand Attention
Child
Alone
Mean Task Completion
35
Cade
23
12
39%
Percent Correct
0%
0%
Frankie

Mean Task Completion
Percent Correct

52
37%

0
0%

0
0%

Joel

Mean Task Completion
Percent Correct

44
62%

1
0%

1
0%

Mark

Mean Task Completion
Percent Correct

51
49%

8
26%

7
31%

Cooper

Mean Task Completion
Percent Correct

39
48%

17
18%

0
0%

Overall,

the results indicated that each child's

target behavior persisted at the highest rate in the alone
condition. Behavior that persists at high levels in the
absence of socially mediated consequences is more likely to
be responsive to treatment with medication. For three of
the children,

the results suggested that target behaviors

might also be responsive to positive reinforcement in the
form of attention or tangible items to various degrees.
Thus, the no interaction and attention conditions appeared
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to be appropriate functional assessment conditions to
evaluate the effects of MPH and placebo in classroom
settings.
Phase 2: Medication Evaluation
Classroom Functional Analysis
Two functional analysis conditions

(attention, no

interaction) were first conducted in the regular classroom
when the child was not receiving medication to further
determine baseline levels of disruptive behavior and task
engagement as compared to analog conditions. The no
interaction condition was used as the classroom equivalent
of the analog functional analysis alone condition. For all
children, the percentage of intervals in which disruptive
behavior occurred were collected during baseline, when
receiving no medication, and across each dosage and placebo
in the attention (top panel of Figures 3 through 7) and no
interaction (lower panel of Figures 3 through 7)
conditions.
Cooper. Figure 3 shows disruptive behavior levels
during Cooper's medication evaluation. During baseline,
disruptive behavior occurred at high rates with an
increasing trend in the attention (mean, 79%; range, 61% to
100%) condition sessions and in 100% of the intervals
during the no interaction condition sessions. Disruptive
behavior was high in the attention condition when Cooper
received either placebo

(mean, 66%; range, 25% to 92%) or

10 mg of MPH (mean, 70%; range, 3% to 98%). During the no
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Figure 3. Percentage of intervals of disruptive behavior
in baseline and across each dosage compared to placebo
in the attention (upper panel) and no interaction (lower
panel) conditions of Cooper's medication evaluation.
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interaction condition, disruptive behavior occurred at
high, stable rates when Cooper received either 10 mg of MPH
(mean, 96%; range, 90% to 100%) or placebo (mean, 90%;
range, 60% to 100%).
The physician reviewed all results and recommended
increasing Cooper's dosage to a medium level of 15 mg of
MPH and a placebo to alternate every two days for eight
days. Alternating every 2 days was selected to minimize
possible multiple treatment interference effects. When
Cooper received the medium dose, disruptive behaviors
decreased quickly and occurred at relatively low and stable
levels during both the attention (mean, 16%; range, 2% to
55%) and no interaction (mean, 32%; range, 0% to 100%)
conditions. Disruptive behavior remained at baseline levels
when Cooper received placebo in the attention (mean, 77%;
range 42% to 97%) and no interaction (mean, 95%: range, 63%
to 100%) conditions.
After reviewing all results,

the physician determined

the 15 mg dose of MPH was effective for Cooper and
recommended terminating the medication evaluation.
C ade. Figure 4 shows the results of Cade's medication
evaluation. During baseline, disruptive behavior was
moderately high during the attention (mean, 55%; range, 53%
to 60%) and no interaction (mean, 45%; range, 41% to 50%)
condition sessions.
Disruptive behavior was moderately high with a
downward trend in the attention condition when Cade
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panel) conditions of Cade's medication evaluation.
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received placebo (mean, 16%; range, 3% to 25%) and
moderately high and variable when he received 5 mg of MPH
(mean, 20%; range, 7% to 55%). During the no interaction
condition, disruptive behavior occurred at similar rates
when he received 5 mg of MPH (mean, 53%; range, 8% to 87%)
or placebo

(mean, 54%; range, 11% to 91%). Disruptive

behavior decreased below baseline levels and was showing a
downward trend when receiving either placebo or 5 mg of
MPH. The downward trend for placebo is unusual, and it is
possible that unexplained sequence effects or multiple
treatment interference may have occurred.
The physician reviewed all results and recommended
increasing Cade's dosage to a medium level of 10 mg of MPH
and a placebo to alternate every two days for eight days.
Disruptive behaviors occurred at a lower and more stable
rate when Cade received 10 mg of MPH (mean, 12%; range, 7%
to 17%) as compared to placebo

(mean, 46%; range 32% to

57%). In the no interaction condition, disruptive behavior
occurred at a lower but more variable rate when Cade
received 10 mg of MPH (mean 36%; range 7% to 83%) as
compared to placebo (mean, 82%; range, 52% to 97%). The
medium dose appeared to stabilize disruptive behavior more
quickly during the attention condition than during the no
interaction condition; however, disruptive behavior did
show a downward trend when Cade received 10 mg of MPH in
the no interaction condition. At the end of the evaluation
phase, disruptive behavior was on a downward trend when
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Cade received 10 mg of MPH and an upward trend with
placebo.
After reviewing all results, the physician determined
the 10 mg dose of MPH was effective for Cade and
recommended terminating the medication evaluation.
Frankie. Figure 5 shows the results of Frankie's
medication evaluation. During baseline, disruptive behavior
occurred at high rates with increasing trends in the
attention (mean, 86%; range, 67% to 100%) and no
interaction (mean, 92%; range, 78% to 100%) condition
sessions.
Disruptive behavior occurred at high and variable
rates during the attention condition when Frankie received
5 mg of MPH (mean, 59%; range, 40% to 72%), and at high
rates with an increasing trend when she received placebo
(mean, 56%; range 32% to 83%). During the no interaction
condition, disruptive behavior occurred at high rates with
an increasing trend when she received 5 mg of MPH (mean,
81%; range, 59% to 94%) and at high rates with a decreasing
trend when she received placebo (mean, 84%; range, 68% to
9 3%). The downward trend for placebo in the no interaction
condition is unusual and contradicts the downward trend
shown with MPH and upward trend with placebo in the
attention condition over the same days. It is possible that
unexplained sequence effects or multiple treatment
interference may have occurred.
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baseline and across each dosage compared to placebo in the
atention (upper panel) and no interaction (lower panel)
conditions of Frankie’s medication evaluation.
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The physician reviewed all results and recommended
increasing Frankie's dosage to a medium level of 10 mg of
MPH and a placebo to alternate every two days for eight
days. During the attention condition, disruptive behavior
was moderately high with a variable but downward trend when
Frankie received 10 mg of MPH (mean 41%; range, 13% to
82%). Disruptive behavior occurred at a higher rate when
she received placebo (mean, 81%; range, 61% to 94%). During
the no interaction condition, disruptive behavior occurred
at highly variable rates when she received 10 mg of MPH
(mean, 65%; range, 15% to 100%) and high and stable rates
with placebo (mean, 89%; range, 78% to 100%) .
The physician reviewed all results and recommended
increasing Frankie's dosage to a high level of 15 mg of MPH
to alternate every two days for eight days. During the
attention condition, disruptive behavior levels decreased
in the attention condition when she received 15 mg of MPH
(mean, 24%; range, 7% to 53%) as compared to placebo

(mean,

73%; range, 40% to 100%). During the no interaction
condition, disruptive behavior showed a downward but
somewhat varied rate when she received 15 mg of MPH (mean,
24%; range, 3% to 58%) and was significantly reduced
compared to placebo (mean, 72%; range, 32% to 97%) at the
15 mg dose.
After reviewing all results, the physician determined
the 15 mg dose of MPH was effective for Frankie and
recommended terminating the medication evaluation.
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J oel. Figure 6 shows the results of Joel's medication
evaluation. During baseline, disruptive behavior occurred
at moderately high levels with an increasing trend in the
attention condition (mean, 39%; range, 17% to 83%) and high
levels with an increasing trend in the no interaction
condition (mean, 63%; range, 17% to 9 3%).
In the attention condition, disruptive behavior levels
were moderately low and stable when Joel received 10 mg of
MPH (mean, 14%; range, 8% to 22%) or placebo (mean, 13%;
range, 7% to 17%) . During the no interaction condition,
disruptive behavior was moderately low and showed
decreasing trends when Joel received 10 mg of MPH (mean,
33%; range, 13% to 58%) or placebo (mean, 27%; range, 17%
to 45%). Disruptive behavior levels decreased compared to
baseline when Joel received either 10 mg of MPH or placebo
in both the attention and no interaction conditions.
The physician reviewed all results and recommended
increasing Joel's dosage to a medium level of 15 mg of MPH
to alternate every two days for eight days. During the
attention condition, disruptive behavior levels increased
and became highly variable when Joel received 15 mg of MPH
(mean, 24%; range, 2% to 73%) but remained low and
relatively stable when he received placebo

(mean, 15%;

range 2% to 85%). During the no interaction condition,
disruptive behavior occurred at moderate and variable rates
when he received either 15 mg of MPH (mean, 37%; range, 0%
to 73%) or placebo (mean, 35%; range, 3% to 70%).
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Figure 6. Percentage of intervals of disruptive behavior
in baseline and across each dosage compared to placebo in
the attention (upper panel) and no interaction (lower
panel)conditions of Joel's medication evaluation.
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After reviewing all results, the physician determined
the 15 mg dose of MPH was also ineffective for Joel and
recommended terminating the medication evaluation.
M ark. Figure 7 shows the results of Mark's medication
evaluation, During baseline, disruptive behavior levels
were moderately high in the attention condition (mean, 28%;
range, 20% to 35%) and high in the no interaction condition
(mean, 7 0%; range, 55% to 87%).
During the attention condition, disruptive behavior
occurred at moderately low and stable levels in the
attention condition when he received 10 mg of MPH (mean,
14%; range, 2% to 25%) and at somewhat higher but stable
levels when he received placebo (mean, 20%; range 13% to
33%). During the no interaction condition, disruptive
behavior occurred at higher levels when he received 10 mg
of MPH (mean, 62%; range, 0% to 94%) than when he received
placebo (mean, 46%; range, 36% to 63%). In both conditions,
disruptive behavior was lower than baseline with a downward
trend when Mark received placebo and higher than baseline
with an upper trend when he received MPH. These results are
unusual and may be related to unexplained sequence effects
or multiple treatment interference.
The physician reviewed the results and recommended
increasing Mark's dosage to a medium level of 15 mg of MPH
and a placebo to alternate every two days for eight days.
Disruptive behavior occurred at higher rates with an
increasing trend when Mark received the 15 mg dose of MPH
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(mean, 31%; range, 0% to 75%) and at lower levels with a
downward trend when he received placebo (mean, 13%; range
5% to 32%). During the no interaction condition, disruptive
behavior occurred at high and variable levels when he
received 15 mg of MPH (mean, 69%; range, 0% to 100%) and a
lower level when he received placebo (mean, 40%; range, 2%
to 100%).
After reviewing all results, the physician determined
the 15 mg dose of MPH was also not effective for Mark and
recommended terminating the medication evaluation.
Task Engagement
Table 7 gives the levels of task engagement for each
child across dosages of MPH and placebo in each condition
of the classroom functional analysis assessments.
Engagement was undifferentiated between low dose of MPH and
placebo in the attention condition for all children.
Engagement improved with the increase in MPH dose over
placebo for Cooper, Cade, and Frankie and remained
essentially unchanged for Joel and Mark. There was a small
decrease in engagement in the attention condition when
Frankie moved to the highest dose of MPH. Joel and Mark's
task engagement were higher when they received placebo than
when they received the medium dose of MPH.
The effects of MPH were not as significant in the no
interaction condition for task engagement; however, Cooper,
Cade, and Frankie showed some improvement from the low to
medium dose. Task engagement decreased for Joel and Mark
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Table 7. Mean Percentage of Intervals for Task Engagement across MPH Dosage and Placebo
for the Attention (ATT) and No Interaction (NI) Conditions
Placebo
High Dose
Placebo
Child
Medium Dose
Placebo
Low Dose
Mean Range Mean Range Mean Range
Mean Range Mean Range Mean Range
18
ATT
62 12-98)
3-45)
Cooper
29 0-92)
33 4-75)
N/A
N/A
8 0-32)
20 0-100)
8
NI
3 0-12)
0-61)
N/A
N/A
Cade

ATT
NI

76
46

45-92)
13-92)

79
45

65-97)
5-88)

83
67

75-90)
17-93)

63
16

40-92)
2-50)

Frankie

ATT
NI

31
19

25-37)
6-42)

42
10

17-62)
3-18)

56
39

33-82)
0-85

20
11

6-39)
0-17)

Joel

ATT
NI

77
60

62-90)
38-82)

82
71

70-90)
58-83)

72
58

85
38-97)
16-100) 45

67-98)
2-97)

N/A
N/A

N/A
N/A

Mark

ATT
NI

74
30

27 -98)
5-93)

79
48

66-87
36-64)

68
28

25-100
0-80)

85
59

72-95)
0-80)

N/A
N/A

N/A
N/A

N/A
N/A
49 (23-72)
38 ( 4-97

N/A
N/A
11 ( 0-30)
11 ( 2-43)

from the low to medium dose. Task engagement was higher for
Mark when he received placebo than when he received either
the low or medium doses of MPH. Task engagement remained
stable in both conditions when Frankie received MPH and
placebo in the high dose evaluation.
Performance Measures
Table 8 gives the performance measures collected
during the classroom functional analysis conditions when
the children were receiving MPH. The data were analyzed in
conjunction with data collected during the functional
analysis analogs

(see Table 6) and used to develop the

interventions in the final phase of the study.
Table 8. Classroom Functional Analysis Performance Measures
No Interaction
Child
Measures
Attention
Cooper
31
Mean Task Completion
3
Percent Correct
13%
0%
Cade

Mean Task Completion
Percent Correct

40
1

13
1%

Frankie

Mean Task Completion
Percent Correct

16
0%

0
0%

Joel

Mean Task Completion
Percent Correct

6
6%

6
0%

Mark

Mean Task Completion
Percent Correct

30
9%

20
0%

Cade completed more tasks in the attention condition
than during the interaction condition. There was no
difference in task accuracy (percent correct) between the
conditions.
Cooper's task completion was higher in the attention
condition. Task accuracy improved in the attention
condition.
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Frankie's task completion was higher in the attention
condition. Frankie completed no task correctly in either
condition.
Joel completed an equal number of tasks in both
conditions. He was more accurate during the attention
condition.
Mark's mean number of completed tasks was higher in
the attention condition. His accuracy was slightly improved
in the attention condition.
Behavior Rating Scales
Table 9 shows the rating scores given by the teachers
and support workers for each of the children when they
received placebo and low, medium, or high dose of MPH.
Across all scales some of the highest scores were given to
Mark when he received placebo and all dosages of MPH even
though the direct observations indicated he did not respond
to MPH. Joel also received consistently high scores when he
received placebo and all dosages of MPH on almost all
scales. For Cade, Cooper, and Frankie, CAP scores were
higher or essentially the same as baseline scores across
all dosages of MPH. The HSQ-R and SSQ-R scales generated
low scores across all dosages and placebo for all children
except Mark. For Mark, the HSQ-R and SSQ-R generated
moderately high to high scores across all dosages and
placebo.
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Table 9. Mean Teacher and Support Worker Behavior Rating Scale Scores
Cade
Cooper
Frankie
Joel
Placebo MPH Placebo MPH Placebo MPH Placebo
CAP/ Support Worker
Baseline
N/A
21
N/A
30
63
N/A
39
28
57
13
19
0
17
Low-dose Evaluation
66
40
Medium-dose Evaluation 53
15
20
29
20
64
N/A
N/A
30
High-dose Evaluation
N/A
N/A
33
N/A
CAP/ Teacher Form
Baseline
N/A
67
N/A
65
9
36
N/A
Low-dose Evaluation
31
63
27
3
54
56
63
40
48
44
Medium-dose Evaluation 36
10
43
23
59
High-dose Evaluation
N/A
N/A
N/A
N/A
38
N/A
HSQ-R/ Support worker
Baseline
33
N/A
11
N/A
1
7
N/A
Low-dose Evaluation
26
0
20
0
0
6
20
24
Medium-dose Evaluation 24
12
7
8
17
6
High-dose Evaluation
N/A
N/A
N/A
N/A
21
27
N/A
SSQ-R/ Teacher
Baseline
38
14
N/A
5
N/A
N/A
15
Low-dose Evaluation
30
3
18
18
18
8
38
14
Medium-dose Evaluation 18
19
3
22
19
11
High-dose Evaluation
N/A
N/A
N/A
12
N/A
4
N/A
SDSERS/ Support Worker
Baseline
69
23
N/A
20
N/A
34
N/A
Low-dose Evaluation
31
37
26
0
14
23
85
Medium-dose Evaluation 42
9
11
18
31
25
59
High-dose Evaluation
N/A
N/A
47
N/A
N/A
39
N/A
SDSERS/ Teacher
Baseline
N/A
17
16
29
N/A
27
N/A
Low-dose Evaluation
2
24
26
34
37
6
46
Medium-dose Evaluation 7
17
10
9
9
26
0
High-dose Evaluation
N/A
N/A
N/A
12
N/A
5
N/A

MPH

Mark
Placebo MPH

N/A
52
44
N/A

100
100
70
N/A

N/A
107
96
N/A

N/A
30
35
N/A

108
104
64
N/A

N/A
60
93
N/A

N/A
29
24
N/A

16
50
55
N/A

N/A
71
39
N/A

N/A
29
17
N/A

72
59
27
N/A

N/A
42
44
N/A

N/A
65
51
N/A

40
61
56
N/A

N/A
112
27
N/A

N/A
30
9
N/A

63
23
3
N/A

N/A
15
5
N/A

The Intervention Rating Profile-15 (IRP-15)
The IRP-15 acceptability rating was given to the
teacher and primary direct support worker

(DSW) prior to

and following implementation of the medication and
behavioral treatment evaluations for each child. Table 10
gives the results of the pre- and post-treatment measures
for the children.
Overall teacher acceptability ratings of the
medication intervention corresponded with the medication
evaluations for each child; however, teacher behavioral
intervention ratings did not correspond with the direct
observations made of these treatments. Following the
medication evaluation, teacher acceptability ratings for
the medication intervention improved for Cade, Cooper, and
Frankie and decreased for Joel and Mark. Teacher
acceptability ratings for the behavioral intervention
increased for Cooper and Frankie, did not change for Cade,
and decreased for Joel and Mark.
Table 10. Intervention Acceptability Ratings for Medication
and Behavioral Treatments
Cooper
Cade
Frankie
Joel
Mark
Medication Pre Post Pre Post Pre Post Pre Post Pre Post
Teacher
53 75
73 100
94 98
63 57
94 50
DSW
61 89
83 91
63 66
73 70
77 89
Behavior
Teacher
DSW

Pre Post
60 60
92 92

Pre Post
37 81
61 91

Pre Post
96 100
78 78

Pre Post
74 46
46 89

Pre Post
97 23
63 89

Support worker acceptability ratings of the medication
intervention corresponded with the medication evaluations
for all children except Mark. The support worker
post-intervention ratings were higher for the medication
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intervention for Cade, Cooper, Frankie, and Mark, and
decreased for Joel. The support worker medication
post -treatment ratings for Mark increased even though the
medication evaluation indicated the MPH was not effective.
Post-treatment support worker acceptability ratings for the
behavioral interventions generally supported the treatment
evaluations for all children but Frankie.
Phase 3: Treatment Evaluation
Behavioral treatments to reduce disruptive behavior
and increase task engagement were developed after analyzing
the levels of disruptive behavior,

task engagement, and

performance measures across the analog and classroom
functional analysis condition sessions. In phase 3, the
three children who responded to MPH received the following
four treatments:

(a) the optimal dose of MPH alone (no

behavioral intervention), (b) MPH plus the behavioral
intervention,

(c) the behavioral intervention with no pill,

and (d) behavioral intervention plus placebo. For the two
children not responding to MPH, a behavioral intervention
was developed targeting the behavioral deficits observed
during the functional analog and classroom conditions.
Behavioral and Medication Treatments for Children
Responding to MPH
Medication and Behavioral Treatment Evaluations
Figure 8 shows the results of the treatment
evaluations made in phase 3 for the three children for whom
an effective dose of MPH was established. The levels of
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Figure 8. Percentage of intervals of disruptive behavior in
baseline attention (ATTN) condition compared to
Methylphenidate (MPH) and behavioral treatments for Cade
(upper panel), Cooper (middle panel), and Frankie (lower
panel). Behavior treatment was differential reinforcement
of alternative behavior (DRA) and graduated compliance (GC)
with a time out (TO) intervention for disruptive behavior.
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disruptive behavior in the baseline attention condition
(left panel) is compared to disruptive behavior levels when
the children received MPH or behavioral treatment alone for
Cade (upper right panel), Cooper

(middle right panel), and

Frankie (lower right panel).
Ca d e . Figure 8 shows Cade's baseline levels of
disruptive behavior in the classroom attention condition
were moderately high and stable (mean, 55%; range 53% to
60%). Disruptive behavior was reduced when Cade received
MPH alone (mean, 16%; range, 8% to 25%) and the behavioral
treatment alone (mean, 19%; range, 11% to 38%); however,
both treatments were equally successful in reducing
disruptive behavior to a stable and relatively low rate.
Cooper. Figure 8 shows Cooper's baseline level of
disruptive behavior

(mean, 79%; range, 61% to 100%) was

high and increasing in the attention condition. Disruptive
behavior was significantly low and stable when he received
MPH alone (mean, 3%; range, 0% to 10%) and was stable and
higher than baseline levels when only a behavioral
treatment was used (mean, 87%; range, 80% to 95%).
Frankie. Figure 8 shows Frankie's baseline levels of
disruptive behavior in the classroom attention condition
were high with an increasing trend (mean, 86%; range, 67%
to 100%) during the attention condition. Disruptive
behavior was reduced in the MPH alone (mean, 25%; range, 5%
to 42%) and the behavioral treatment alone condition (mean,
39%; range, 30% to 44%). MPH initially reduced disruptive
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behavior to a low level; however, there was an increasing
trend over the four doses.
Effects of Behavioral Treatment Alone and with MPH
Table 11 gives the results of the MPH plus behavioral
treatment (MPH + BT) and behavioral treatment plus placebo
(BT + Placebo) conditions on disruptive behavior and task
engagement for the three children for whom an effective MPH
dose was established.
Table 11. Disruptive and Engagement Behavior Percentage
Means across Treatments
MPH + BT
BT + Placebo
Disruptive
Engagement
Disruptive
Engagement
Mean% Range Mean% Range
Mean% Range Mean% Range
7-30
84
16
7-32
Cade
15
73-88
74
53-82
Cooper

13

0-33

95

88-100

66

28-100

42

0-93

Frankie 44

32-62

85

74-98

57

39-67

90

89-92

For Cade, combining behavioral treatment with either
placebo or MPH had similar effects on disruptive behavior
levels; however,

task engagement increased when he received

MPH and behavioral treatment. For Cooper, disruptive
behavior decreased and task engagement increased when he
received MPH rather than placebo during the behavioral
treatment. For Frankie, disruptive behavior decreased in
the MPH plus behavioral treatment condition; however,

there

was a slight decrease in task engagement when she received
MPH rather than placebo with the behavioral treatment.
Task Engagement
Table 12 shows the mean levels of task engagement
maintained by Cade, Cooper, and Frankie during baseline,
during MPH alone conditions, and during behavioral
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treatment conditions

(i.e., with placebo, with no pill).

Both treatments increased task engagement for all three
children; however, MPH alone was more effective in
increasing task engagement than the behavioral intervention
alone.
Table 12. Task Engagement for Treatments Compared to
Baseline for Children Responding to MPH_____________________
Child
Baseline
MPH
Behavioral. Treatment
Mean Range
Mean Range
Mean Range
Cade
46% 40%- 50%
77% 7 0%- 87 %
56% 49%-67%
Cooper

20%

0%- 44%

100%

Frankie

11%

0%- 25%

88%

100%

44%

17 % -85%

83%-100%

73%

58% -84%

Behavioral Treatment Evaluations for Children
Who Did Not Respond to MPH
Behavioral Treatment Results
Figure 9 shows the results of the phase 3 treatment
evaluations for the two children for whom an effective dose
of MPH was not established. The levels of disruptive
behavior in the baseline attention condition (left panel)
is compared to disruptive behavior levels when the children
received a function-related behavioral treatment for Joel
(right upper panel) and Mark (right lower panel).
J oel. Figure 9 shows Joel's baseline level of
disruptive behavior in the attention condition (mean, 39%;
range, 17% to 83%) was moderately high with an upward
trend. Disruptive behavior occurred at stable and low rates
when Joel received a behavioral treatment (mean, 4%; range,
0% to 9%) .
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Figure 9.Percentage of intervals of disruptive behavior in
baseline attention (ATTN) condition compared to behavioral
treatments. For Joel (upper panel), behavioral treatment
was functional communication training (FCT) with verbal
reprimand for disruptive behavior. For Mark (lower panel),
behavior treatment was differential reinforcement of
alternative behavior (DRA) and graduated compliance (GC)
with verbal reprimand for disruptive behavior.
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M a r k . Figure 9 shows Mark's baseline level of
disruptive behavior in the attention condition (mean, 28%;
range, 20% to 35%) was moderately high and stable.
Disruptive behavior occurred at stable and low rates when
Mark received a behavioral treatment (mean, 4%; range, 0%
to 14%).
Task Engagement during Behavioral Treatment
Table 13 shows the mean levels of task engagement
maintained by Joel and Mark during baseline and behavioral
treatments. Task engagement increased significantly for
Joel and marginally for Mark.
Table 13. Task Engagement Percentage Means and Ranges for
Joel and Mark's Behavioral Treatments
Behavioral Treatment
Child
Baseline
Mean
Range
Mean
Range
Joel

35%

0% - 68%

93%

86% - 100%

Mark

72%

67% - 78%

85%

53% - 100%

Performance Measures
Table 14 shows the performance measures collected
during the phase 3 treatments. The data can be compared to
the measures collected in the functional analysis analogs
(Table 6) and classroom functional assessments

(Table 8) to

compare task productivity (mean task completion) and
accuracy (percent correct) across treatments.
MPH and behavioral treatment had similar effects on
Cade's productivity; however, productivity increased when
the treatments were combined (MPH+BT). Accuracy was higher
with MPH than with behavioral treatment but was highest
when the two treatments were combined.
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Table 14. Performance Measures across Treatment Conditions
Measures
BT
Child
"
MPH
MPH+BT
Cade
Mean Task Completion
27
26
35
Percent Correct
39%
43%
63%
Cooper

Mean Task Completion
Percent Correct

94
97%

16
45%

83
99%

Frankie

Mean Task Completion
Percent Correct

7
27%

3
67%

4
88%

Joel

Mean Task Completion
Percent Correct

N/A
N/A

46
93%

N/A
N/A

Mark

Mean Task Completion
Percent Correct

N/A
N/A

40
79%

N/A
N/A

Cooper's productivity was highest with MPH and lowest
with behavioral treatment. Combined treatments had a lower
task completion rate than MPH alone. Accuracy was higher
when he received MPH than behavioral treatment. Combining
the treatments showed minimal improvement; however, a
ceiling effect may have been in place.
Frankie's productivity was highest in the MPH
condition but low across all treatments. Accuracy was low
with MPH, increased with the behavioral treatment, and
increased again when the treatments were combined.
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DISCUSSION
The current study uses a three-phase,

individualized

assessment with multiple behavior measures across several
domains to determine individual medication effects for five
children with severe to profound mental retardation. This
study also demonstrates the utility of a single-subject
design and functional analysis in determining the separate
and combined effects of stimulant medication and behavioral
treatments on disruptive behavior and task engagement for
individual participants.
In the first phase,

the analog functional analyses for

each child showed that the highest levels of disruptive
behavior occurred in the alone and attention conditions.
The results identified two children with disruptive
behaviors that did not appear to be influenced by any
socially mediated reinforcement. Disruptive behaviors
appeared most likely related to socially mediated
reinforcement in the form of attention or some unknown
variable associated with the alone condition for the
remaining three children.
The second phase used direct classroom observation and
behavior rating scales to evaluate MPH-related changes in
disruptive behavior and task engagement in attention and no
interaction conditions within a multielement design.
Positive effects for MPH were found for three of the five
children (i.e., reductions in disruptive behavior
concurrent with increased levels of task engagement).
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The third phase investigated the separate and combined
effects of MPH and behavioral interventions for three of
the children and behavioral treatment alone for the two
children not responding to MPH. The results suggest that
there were individual medication and behavioral treatment
effects for these children.
The majority of the studies evaluating MPH treatment
effects have targeted children with average intelligence,
used subjective care provider reports and behavior rating
scales, reported results based on between-group statistical
analyses, and limited assessments to one area of
functioning (Gulley & Northup, 1997). A limited number of
stimulant medication efficacy studies with children with
ADHD and average intelligence have combined a
single-subject experimental design, standardized drug
evaluation procedures, and multiple behavioral assessment
measures across dosages (Gulley & Northup, 1997; Northup,
et al., in press; 1999).
A small number of methodologically sound,
single-subject designs have compared MPH to behavioral
treatments for children with mental retardation (Ayllon et
al., 197 5; Pelham et al., 19 80, Shafto & Sulzbacher,

1977;

Wulbert &. Dries, 1977) . Two studies have used
single-subject designs to make controlled comparisons of
baseline conditions, a behavioral intervention alone, and
the combination of MPH and a behavioral intervention for
the treatment of disruptive behavior in children with mild
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to moderate mental retardation (Schell et al., 19 86;
Johnson et al., 1994). Blum et al.

(1996) targeted the

disruptive behaviors of children with severe to profound
mental retardation in a single-subject experimental design
with a significantly large number of data points over
multiple medication conditions to document the simple and
combined beneficial effects of stimulants and behavioral
treatments.
This study extends Blum et a l . (1996) by using a
single-subject design and functional analysis to evaluate
the effects of MPH and behavioral treatment for 5 children.
This study also extends the Gulley and Northup (1997) and
Northup et a l . (1999; in press) classroom evaluations of
MPH effects for children with average intelligence and ADHD
to children with severe to profound mental retardation and
disruptive behavior. As with these earlier studies,

this

protocol systematically assesses a variety of behaviors
(e.g., disruptive classroom behaviors, engagement,
performance) and uses several methods (e.g., behavior
scales, direct observations, preference assessments,
functional analyses).
A limited number of stimulant efficacy studies have
included behavioral treatments based on functional analysis
(Cooper et a l ., 1993; Fisher et a l ., 1989; Kayser et a l .,
1997; Northup et a l ., 1999; in press). This study used
functional analysis to describe medication effects on
specific classroom behaviors as well as to determine
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effective function-related behavioral treatments. Analog
data were used to select pertinent controlled conditions
for classroom evaluation of MPH effects. Thus, this studyreplicated the use of classroom functional analysis to
establish the function of disruptive classroom behaviors
and illustrated a strategy for evaluating the treatment
effects of medication interventions across multiple
behaviors

(Northup et a l ., 1999; in press).

The Northup et al.

(1999; in press) conclusions on

drug-behavior interactions were based on analog conditions
in a university lab setting. This study extends functional
assessments directly into the child's actual classroom with
instructional tasks taken from the child's current
curriculum. The treatment evaluation (phase 3) also
attempts to assess the more complex differential
reinforcement programs associated with greater treatment
effects in the literature.
Using an analog analysis to set up the classroom
assessment conditions may be a useful protocol to identify
components of behavioral and medication treatment packages
for children with disruptive behaviors that do not clearly
differentiate in traditional functional analysis. This
method accomplishes an effective classroom analysis of
medication effects and allows a more complete evaluation of
within-subject effects.
Failure to control for antecedent and consequent
events and contextual variables has been a major limitation
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in many previous drug studies conducted for persons with
mental retardation (Aman & Singh, 1991). Thus, the
functional analysis procedure used in this study provided
controlled environmental conditions to evaluate MPH effects
in the classroom. In phase 2, the children who responded to
MPH displayed less disruptive behavior in both the no
interaction and attention conditions when receiving an
effective dose of MPH as compared to placebo. There did not
appear to be any differential effect across the two types
of consequences for any participant.
These results are consistent with previous studies
that suggest MPH effects are most likely to be mediated by
antecedent events (Northup et al., 1997; 1999; in press;
Whalen et al., 1979, Wilkison, Kircher, McMahon, & Sloane,
1995). For example, Northup et al.

(1999; in press)

showed

teacher proximity to interact with MPH effects across
ignore, reprimand, and time-out conditions. One possible
explanation is that the discriminative properties of the
adult were altered when the child received MPH.
Medication is frequently prescribed for the disruptive
behavior of children with mental retardation; however,
medication efficacy studies with this population should
consider the degree to which the behavior is influenced by
environmental conditions (Thompson et al., 1993) .
Functional analysis has proven utility in developing
behavioral treatments for persons with mental retardation.
This study suggests that similar functional analysis
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procedures should be considered when assessing medication
treatments for this population (Baumeister et a l ., 1993;
Blum et a l ., 1996) .
During the past 10 years, numerous between-group
studies have validated stimulant use in the ADHD population
for children with average intelligence and mild to moderate
mental retardation; however,

the between-group studies

targeting children with severe to profound mental
retardation have not demonstrated consistent positive
effects. The cognitive and adaptive deficits of children
with mental retardation make it more difficult to assess
behavioral improvement and stimulant side effects. Direct
observation of medication effects may be a more beneficial
method for children with severe to profound mental
retardation.
The treatment of choice for the disruptive behavior of
children with mental retardation is generally medication
prescribed by physicians and behavioral treatments
developed by behavior analysts. Traditionally,

the two

disciplines have worked independently. Blum et a l . (1996)
urged medical practitioners and behavior analysts to
collaborate in order to more accurately monitor dose
response and drug-behavior interactions. Physicians
typically rely on subjective reports, whereas behavior
analysts can collect objective data useful to treatment
teams making pharmacological decisions.
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These results are also consistent with other studies
that have shown positive medication effects may not always
be apparent to the classroom teacher

(e.g., Gulley and

Northup, 1997). In this study, support worker ratings of
MPH side-effects for Cade were highest during baseline when
he received no pill as compared to direct observations
which indicated reduced disruptive behavior and increased
task engagement when he received MPH. Teachers rated
Frankie's attentiveness and disruptive behavior low when
she received either placebo or MPH. These results support
previous suggestions that teacher and care provider reports
are subject to informant bias (Stoner et al., 1994; Shapiro
& Kratochwill, 19 88). Thus, teacher and parent ratings can
be useful supplements to direct observations of relevant
behavioral variables within the classroom setting and
during academic tasks but have limited utility as repeated
daily measures

(Gulley & Northup, 1997) .

The care provider acceptability ratings deserve
special mention. Poling and LeSage (1995) report
acceptability ratings are important in assessing the social
validity of psychotropic treatments. In this study, the
post-treatment acceptability ratings for both the
behavioral and medication interventions varied according to
medication response. In general, post-treatment care
provider ratings of both the medication and behavioral
treatments improved for Cade, Cooper, and Frankie.
Post-treatment care provider ratings for Mark and Joel's
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behavioral treatments were inconsistent. Post-treatment
teacher acceptability ratings for Joel and Mark's highly
effective behavioral interventions decreased from
pre-treatment acceptability ratings. Support worker
acceptability ratings of MPH did not decrease even though
neither child responded to MPH. Unlike the daily
administered rating scales,

the acceptability scales were

only administered as pre- and post-treatment measures.
Therefore, these results were not influenced by repetitive,
daily ratings. In an effort to develop a standardized
methodology,

the same acceptability measure was adapted for

both interventions. Future studies should consider
developing separate measures for alternate treatments.
A number of procedural issues and limitations should
be noted. First, the analog assessments were highest during
the alone condition for all children and identified a
likely environmental influence on disruptive behavior for
two of the children. The behavioral treatments were limited
to antecedent manipulations and attempts to identify
effective competing reinforcers. Thus, the inability to
identify a maintaining variable for the disruptive behavior
that could be removed or modified limited the effectiveness
of the behavioral treatment.
Second, this evaluation involved a large number of
sessions

(mean, 90; range, 7 8 to 120) and required that the

therapist and one to two observers be available for thirty
minutes one-hour after medication administration for each
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child. Additionally,

the two, 10-minute, classroom

conditions required approximately 30 minutes, twice daily,
to set up and complete. The behavior interventions were
labor intensive, and teacher implementation was not
explored. Future research should explore a briefer
assessment method (e.g., minute-by-minute analysis), a
teacher inservice protocol, and follow-up booster sessions.
Placebo was alternated with MPH to control for
observer bias and to rule out the possibility that the
child might respond differently on "no pill" days. This
alternating treatment procedure appears to have contributed
to an unusual downward trend for placebo that was possibly
related to unexplained sequence effects or multiple
treatment interference; this effect was found at some dose
levels for both the children that responded to medication
and those that did not.
As noted by Thompson et al.

(1993), drug efficacy

studies including children with developmental delays should
also assess behavior deficits that might be associated with
the disruptive behavior. Joel and Mark's disruptive
behaviors appear to have been related to deficits in basic
communication skills and appropriate classroom behaviors
(e.g., recruiting, waiting). Neither child benefitted from
medication and their interventions did not require the more
complex treatments generated from the functional analyses
of the other children. In fact, their two 5 -minute
preference assessments were probably more beneficial in the
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development of their behavioral interventions than the 54
functional analysis sessions. Future research is needed to
develop a systematic protocol to identify, assess, and
train necessary classroom behaviors

(e.g., appropriate

attention seeking, waiting skills) in this population.
The literature indicates children with severe to
profound mental retardation are more likely to develop
side-effects with stimulant medication use; however,

the

behavior rating scales used with the average-IQ ADHD
population have limited utility with the children in this
study. Rather than eliminating these children from future
studies, researchers should develop operational definitions
of behaviors commonly exhibited by children medicated with
MPH (e.g., behavior tics, social withdrawal) and make
brief, controlled observations in natural settings during
medication trials.
To summarize, this study has extended a growing body
of behavioral analytic research that evaluates stimulant
dosage effects on an individual basis using multiple
assessment measures across several behavioral variables. It
is the second study to use an experimental design to
document beneficial effects of stimulants in children with
severe to profound mental retardation (Blum et al., 1996).
The current study is unique in its use of functional
analysis to assess medication effectiveness as well as
develop appropriate behavioral treatments. Future research
might include this method to evaluate the functional
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properties of problem behaviors in relation to medication
status or develop a relatively practical and efficient
model for assessing the simple and combined effects of MPH
and function-related behavioral interventions within
natural classroom settings.
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APPENDIX
CONSENT FORM
fUaflll________________ _________________________________________
AND A Q R I C U L T U R A L
Department ol Psychology
236 Audubon Hall
Baton Rouge, LA 70803-55011

AND

MECHANICAL

COLLEGE

PARENTAL PERMISSION FOR RESEARCH PARTICIPATION

Project Title:

A Comprehensive Functional Assessment of the Effects of Methylphenidate on the Disruptive Behavior
of Children with Severe Mental Retardation

Performance Site: St. Maty Training School

Investigators:

The following investigators are available for questions at the phone numbers below:
Name: Victoria Swanson
John Northup, Ph.D.
LSU Dept of Psychology
LSU Dept of Psychology
(318) 640-2501
(504) 388-4112

Purpose of Study:

This is a research project designed to assist SL Mary Training School's psychology and medical
personnel in developing a comprehensive assessment procedure using multiple behaviors in a variety
of settings (a) to determine an optimal dose, if any, of Ritalin, (b) to establish any differences in
medication effects at various doses as well as across various child target aberrant behaviors, and (c)
to assess academic or training performance, class or training room behavior, attention, social
Interactions, and teacher or care provider ratings of child behavior. A methodology will be developed
by which existing staff will be able to assess the usefulness of present medication status (medication,
no medication) with children who have exhibited disruptive behavior or whose behavior has
significantly impaired their educational and training progress.

Number of Participants:

This study will include 5 to 8 children residing at SL Maiys Training School and currently
receiving methylphenidate (Ritalin).

Inclusion Criteria:

The study includes children with severe to profound mental retardation, aged 6-18 years who have
been prescribed Ritalin for the treatment of disruptive and attentive behaviors in educational and/or
training settings.

Exclusion Criteria:

Children younger than 5 or older than 18, who are not enrolled at SL Mary's Training School, who
receive addWonal psychoactive medication, tor whom the facility does not currently have consent to
administer Ritalin, and those children not previously referred to the Interdisciplinary team tor medication
consideration will be excluded from this study.

Description of the Study:

As a participant in this study, your child's care providers will be asked to complete
questionnaires, and participate in interviews. An initial functional analysis will be conducted
when the child is not on medication, and will assist in determining the environmental events that
may be affecting the disruptive behavior. Brief assessment observations will be made in
situations which simulate problematic times for your child. For example, assessment situations
will include accomplishing a training task, working one-on-one with a support provider, and
when atone and unengaged. This information will be used to develop an effective behavior
intervention. The child’s behavior will then be evaluated on and off medication in the classroom.
This will be accomplished by administering the child various therapeutic doses of medication
and a placebo (fake pill) on alternating days and evaluating his or her behavior in social,
classroom, and one-on-one training situations. Direct observations and rating scales will be
used to determine the most effective dose in each situation. The placebo assesses whether or
not medication is as effective as medication without the child or care providers being aware that
no medication has been given. This design uses a double blind procedure to ensure that
participants, medteation givers, and observers are not influenced by prior knowledge of the
research design. All participants will know the child received a pill prior to assessment;
however, no one will know if the pill was a placebo or Ritalin. Thus, the medication will be
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dspensed and packaged by the pharmacist in a coded order that only the prescribing
physician will know. Ail doses will be the same color and each dose will be blister packed in a
manner that doses cannot be confused by the nursing staff. At the end of each dose level
assessment, the code will be broken by the prescribing physician and the assessments and
observations will be matched to dose level and placebo. This information will be used by the
physician to make decisions about future medfcation trials. A behavior intervention based on
the initial functional analysis will be developed for your child. Your child will then receive a
placebo (fake pill’ ) the same assessments win be completed but a behavior intervention will be
used to manage the behavior. This assessment will tell you whether or not medication is more
effective than an appropriate behavior intervention. Your child will be involved in this
assessment for 3 to 5 weeks.
Benefits: Potential benefits of this study is the development of effective behavioral and medication interventions which may
help your child increase appropriate behavior, social interaction, and academic engagement Parents and St.
Mary's staff will be offered feedback on each child's performance. The information can be used to develop an
appropriate behavior treatment program.
Risks/Discomforts:

This study does not provide any additional risks for your child. The only known risks will be the side
effects of the Ritalin for which your child has already been prescribed. Your consent for administration
of this mediation has already been obtained. An explanation of potential side-effects of this medication
was provided by the training facility when the medication was prescribed.

Rloht to Refuse:

Your agreement to allow your child to participate in this prefect is voluntary. You have the right to
withdraw your child from this project at any time, and you may do so by contacting the investigators.

Withdrawal/removal: The medication administered in this study is being supervised by the medical staff at S t Mary's
Training School. The medical staff may discontinue the medication if warranted or remove the child
from the study if indicated.
Alternatives:

Privacy:

This study evaluates three treatments (e.g., medication, no medication, and behavior intervention) and
several types of assessments. Every participant will be evaluated in each treatment. At the end of this
study, alternatives will be available to each participant

The results of this study may be published. The privacy of participants will be protected and the identify of
participants will not be revealed. All information will be kept confidential.

Release of Information:

The facility and school records of the participants in this study may be reviewed by
investigators, but participant identify will be kept secret.

Financial Information. There will be no cost tor participation in this study.
Signatures: The study has been discussed with me and all my questions have been answered. I understand that if I have
questions about subject rights, or other concerns, I can contact the Vice Chancellor or the LSU office of Research and
Economic Development at 388-5833.1agree with the terms above and acknowledge I have been given a copy of the
consent form.

Signature of the Parent/Guardian

Date

Witness

Date

Investigators)

Date

The parent/guardian has indicated to me that they are unable to read. I certify that I have read this consent form to the
parent/guardian and explained that by completing the signature line above the parent/guardian has given permission tor their
child to participate.

Signature of Reader

Date
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